<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Journal of Infection and Chemotherapy via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Journal of Infection and Chemotherapy' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Journal+of+Infection+and+Chemotherapy&t=Journal+of+Infection+and+Chemotherapy&s=Search&f=source]]></link>
        <lastBuildDate>Wed, 08 Feb 2012 18:15:45 +0100</lastBuildDate>
        <item>
            <title>Antimicrobial susceptibility and genetic characteristics of Haemophilus influenzae isolated from community-acquired respiratory tract infection patients in Shanghai City, China</title>
            <link>http://www.medworm.com/index.php?rid=5668184&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg2701k568g427046%2F</link>
            <description>In this study we investigated 37
 H. influenzae strains isolated from patients with community-acquired respiratory tract infections (CARTI) in Shanghai city between Dec
 2008 and Apr 2009. H. influenzae clinical isolates were identified, and β-lactamase production tests were conducted and minimal inhibitory concentrations
 (MIC) were measured. Pulsed-field gel electrophoresis (PFGE) was introduced as an effective fingerprinting method. Two isolates
 (5.4%) were verified as serotype b strains, and 30 strains (81.1%) were nontypeable H. influenzae. Furthermore, 10 (27.0%) were β-lactamase-producing ampicillin-resistance (BLPAR) (TEM-1 type) strains, 11 (29.8%) were low-β-lactamase-nonproducing
 ampicillin-resistant H. influenzae (Low-BLNAR) strains, and the rest were β-lactamase-negative...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5668184</comments>
            <pubDate>Fri, 03 Feb 2012 07:22:05 +0100</pubDate>
            <guid isPermaLink="false">5668184</guid>        </item>
        <item>
            <title>Should urologists care for the pharyngeal infection of Neisseria gonorrhoeae or Chlamydia trachomatis when we treat male urethritis?</title>
            <link>http://www.medworm.com/index.php?rid=5668185&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F857k5k2r43205332%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Detection of Neisseria gonorrhoeae (NG) or Chlamydia trachomatis (CT) from the pharynx of women or men is not uncommon. However, there is no recommendation how urologists should care for
 the pharyngeal infection of men with urethritis in Japan. The aim of this study is to clarify the prevalence of NG or CT infection
 in the pharynx of men and to show a recommendation for urologists. The Japanese reports about the detection of NG or CT from
 the pharynx or the oral cavity of men in Japan are reviewed in the literature from 1990 to 2011. The prevalence of NG or CT
 in the pharynx was 4% or 6% in men who attended clinics, and 20% or 6% in men who were positive for NG or CT from genital
 specimens, respectively. Single 1-g dose ceftriaxone was recommended to treat pharynge...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5668185</comments>
            <pubDate>Fri, 03 Feb 2012 07:22:04 +0100</pubDate>
            <guid isPermaLink="false">5668185</guid>        </item>
        <item>
            <title>Yersinia enterocolitica bacteremia and enterocolitis in a previously healthy 20-month-old girl</title>
            <link>http://www.medworm.com/index.php?rid=5668186&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3485146650g81713%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;
 Yersinia enterocolitica is a gram-negative bacillus that can cause illness ranging from a self-limiting enterocolitis to life-threatening bacteremia.
 Y. enterocolitica biotype 1B, serotype O:8 (1B/O:8), is the most pathogenic of the Yersinia species because of the presence of the high-pathogenicity island and the Yersinia virulence plasmid (pYV). Here, we report a pediatric case of Y. enterocolitica 1B/O:8 bacteremia and enterocolitis. A 20-month-old girl was admitted to hospital with fever, pharyngitis, and abdominal
 pain on day&amp;nbsp;2. Blood culture on admission was positive for Y. enterocolitica 1B/O:8. Stool culture on day&amp;nbsp;5 after cefotaxime treatment was also positive for Y. enterocolitica 1B/O:8, but only after cold enrichment at 4°C for 3&amp;nbsp;weeks. PC...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5668186</comments>
            <pubDate>Thu, 02 Feb 2012 18:14:00 +0100</pubDate>
            <guid isPermaLink="false">5668186</guid>        </item>
        <item>
            <title>A case of novel swine influenza A (H1N1) pneumonia complicated with virus-associated hemophagocytic syndrome</title>
            <link>http://www.medworm.com/index.php?rid=5649399&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7k43148540776612%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Influenza related to complications such as pneumonia and encephalitis have sporadically been reported. However, influenza
 A (H1N1)-virus-associated hemophagocytic syndrome (VAHS) has rarely been reported. A 39-year old woman complained of high
 fever and was referred to us. Chest infiltrations in both lungs and a positive polymerase chain reaction (PCR) for novel swine-origin
 influenza A (H1N1) in bronchial alveolar lavage fluid (BALF) specimen was confirmed and she was diagnosed with influenza A
 (H1N1) pneumonia. Pancytopenia was found, and hemophagocytic syndrome (HPS) was diagnosed by bone marrow aspiration. Following
 intravenous administration of antiflu drug and combination therapy of steroid pulse and erythromycin IV, the patient’s respiratory
 dysfunction a...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649399</comments>
            <pubDate>Mon, 30 Jan 2012 06:32:07 +0100</pubDate>
            <guid isPermaLink="false">5649399</guid>        </item>
        <item>
            <title>Evaluation of the safety and efficacy of liposomal amphotericin B (L-AMB) in children</title>
            <link>http://www.medworm.com/index.php?rid=5649400&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn48j3h54300l7362%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A multicenter, uncontrolled clinical study has been conducted to evaluate the safety, efficacy, and pharmacokinetics of liposomal
 amphotericin B (L-AMB) in children. In this article, the safety and efficacy of L-AMB are discussed. Subjects were diagnosed
 with invasive fungal infection (definitely diagnosed cases), possible fungal infection (clinically diagnosed cases), and febrile
 neutropenia with suspected fungal infection (febrile neutropenia cases). Of the 39 subjects treated with L-AMB, 18 received
 a definite (11) or clinical (7) diagnosis of invasive fungal infection. In these subjects, excluding one unevaluable subject,
 L-AMB was effective in nine out of 17 subjects (52.9%). Of 12 febrile neutropenia cases, improvement in clinical symptoms,
 etc., was observe...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649400</comments>
            <pubDate>Mon, 30 Jan 2012 06:32:06 +0100</pubDate>
            <guid isPermaLink="false">5649400</guid>        </item>
        <item>
            <title>Discrepancy of in-vitro data and clinical efficacy of micafungin against Candida tropicalis endophthalmitis</title>
            <link>http://www.medworm.com/index.php?rid=5649401&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd7912674jxr47775%2F</link>
            <description>We report findings for a 74-year-old woman with Candida tropicalis endophthalmitis for whom an increase in β-d-glucan level and worsening of endophthalmitis were observed after intravenous injection of micafungin, an echinocandin antifungal
 agent. Endogenous endophthalmitis caused by C. tropicalis developed in both eyes. On the basis of her surgical history, laboratory data, and lesions, tentative diagnosis of fungal
 endophthalmitis was made. She was then treated with fluconazole and itraconazole, but the β-d-glucan level did not decrease, and there was no improvement of the endophthalmitis. The fluconazole was discontinued and
 replaced by micafungin. Unexpectedly, the level of β-d-glucan increased and endophthalmitis did not improve. The micafungin was immediately stopped and replac...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649401</comments>
            <pubDate>Mon, 30 Jan 2012 06:32:03 +0100</pubDate>
            <guid isPermaLink="false">5649401</guid>        </item>
        <item>
            <title>Calcaneal osteomyelitis due to Achromobacter xylosoxidans: a case report</title>
            <link>http://www.medworm.com/index.php?rid=5649403&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F461465556u380382%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;
 Achromobacter xylosoxidans (A. xylosoxidans) has been described as an opportunistic pathogen causing infection. The case we describe is that of an elderly man who had
 osteomyelitis of calcaneal bone caused by A. xylosoxidans. As far as we are aware there are only 5 cases of osteomyelitis with A. xylosoxidans in the literature. Impaired defensive mechanism of the foot in direct contact with this waterborne bacterium can cause this
 disease. Because of the high level of antibiotic resistance of this bacterium, clinically more attention should be paid to
 patients who have impaired defensive mechanisms in their extremities, for example free flaps.
 
 
	Content Type Journal ArticleCategory Case ReportPages 1-4DOI 10.1007/s10156-012-0373-zAuthors
		Kadri Ozer, Ankara Rese...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649403</comments>
            <pubDate>Mon, 30 Jan 2012 06:32:02 +0100</pubDate>
            <guid isPermaLink="false">5649403</guid>        </item>
        <item>
            <title>First report of a thyroid abscess in the pediatric age group caused by Arcanobacterium haemolyticum</title>
            <link>http://www.medworm.com/index.php?rid=5649402&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc0r169w601207866%2F</link>
            <description>We report a 2-year-old girl with thyroid abscess who
 presented with fever and an anterior painful neck mass. Culture of the aspirated fluid yielded Arcanobacterium haemolyticum, which is one of the etiologies of pharyngitis and rash in children and, especially, young adults. As far as we are aware
 this is the first report of thyroid abscess in the pediatric or adult age group caused by Arcanobacterium haemolyticum.
 
 
	Content Type Journal ArticleCategory Case ReportPages 1-3DOI 10.1007/s10156-011-0349-4Authors
		Shirin Sayyahfar, Department of Pediatric Infectious Diseases, Ali Asghar Children Hospital, Tehran University of Medical Sciences, Vahid Dastgerdi Street, Shariati Street, Tehran, 1919816766 IranSeyed Javad Nasiri, Department of Pediatric Surgery, Ali Asghar Children Hospital,...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649402</comments>
            <pubDate>Mon, 30 Jan 2012 06:32:02 +0100</pubDate>
            <guid isPermaLink="false">5649402</guid>        </item>
        <item>
            <title>Evaluation of Seeplex® STD6 ACE Detection kit for the diagnosis of six bacterial sexually transmitted infections</title>
            <link>http://www.medworm.com/index.php?rid=5620938&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd7246228676971u6%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Traditionally, the diagnosis of bacterial sexually transmitted infection (STI) has been dependent on the isolation of the
 causative pathogens by culturing endocervical or urethral swab specimens on selective media. While such procedures typically
 provide excellent diagnostic accuracy, they are often time-consuming and expensive. A multiplex polymerase chain reaction
 (PCR) assay, based on a semi-automated detection system, was evaluated for the detection of six STI causative organisms. The
 Seeplex® STD6 ACE (auto-capillary electrophoresis) Detection assay employed six pairs of dual priming oligonucleotide (DPO™) primers
 specifically targeted to unique genes of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Ureaplasma urealyticum, Mycoplasma ...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5620938</comments>
            <pubDate>Wed, 18 Jan 2012 06:51:44 +0100</pubDate>
            <guid isPermaLink="false">5620938</guid>        </item>
        <item>
            <title>Post-operative infection and prophylactic antibiotic administration after radical cystectomy with orthotopic neobladder urinary diversion</title>
            <link>http://www.medworm.com/index.php?rid=5620939&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn5ng37v42r615030%2F</link>
            <description>In conclusion, our data showed that PAA with TAZ/PIPC with a shorter duration PAA (within
 72&amp;nbsp;h) might be recommended for radical cystectomy with orthotopic neobladder reconstruction. A prospective study based on
 our data is desirable to establish or revise guidelines for prophylactic medication for preventing post-operative infection
 after radical cystectomy with orthotopic neobladder urinary diversion.
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-6DOI 10.1007/s10156-011-0360-9Authors
		Katsumi Shigemura, Department of Urology, Shinko Hospital, 1-4-47 Wakihama-cho, Chuo-ku, Kobe, Hyogo 651-0072, JapanKazushi Tanaka, Division of Urology, Department of Organs Therapeutics, Faculty of Medicine, Kobe University Graduate School of Medicine, Kobe, 650-0017 JapanMinor...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5620939</comments>
            <pubDate>Tue, 17 Jan 2012 07:05:05 +0100</pubDate>
            <guid isPermaLink="false">5620939</guid>        </item>
        <item>
            <title>Minimal effects of Darunavir on adipocyte differentiation and metabolism in 3T3-L1 cells</title>
            <link>http://www.medworm.com/index.php?rid=5598876&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw633366146314457%2F</link>
            <description>This study suggests that the decrease in lipolysis
 observed after DRV treatment could explain, at least in part, the lower plasma lipids observed in patients under DRV/r treatment
 in comparison with other drugs. The lack of effects of RTV co-treatment on glucose and lipid metabolism emphasizes the safety
 of this treatment.
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-9DOI 10.1007/s10156-011-0361-8Authors
		Patricia Pérez-Matute, HIV and Associated Metabolic Alterations Unit, Infectious Diseases Area, Center for Biomedical Research of La Rioja (CIBIR), Piqueras, no 98, 26006 Logroño, SpainLaura Pérez-Martínez, HIV and Associated Metabolic Alterations Unit, Infectious Diseases Area, Center for Biomedical Research of La Rioja (CIBIR), Piqueras, no 98, 26006 Logroñ...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5598876</comments>
            <pubDate>Fri, 13 Jan 2012 17:18:37 +0100</pubDate>
            <guid isPermaLink="false">5598876</guid>        </item>
        <item>
            <title>Investigation and threshold of optimum blood concentration of voriconazole: a descriptive statistical meta-analysis</title>
            <link>http://www.medworm.com/index.php?rid=5583563&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa5115n4860723183%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Voriconazole (VRCZ) reportedly possesses a broad spectrum of antifungal activity against Aspergillus spp. and Candida spp., and the blood concentration of VRCZ is correlated with both the efficacy and the adverse effects of this drug. Monitoring
 of the blood concentration target level of VRCZ has not yet been widely adopted in the medical field, and no evidence concerning
 this target level has been reported. Accordingly, we used a meta-analysis to investigate the optimal blood concentration of
 VRCZ. Using data from 12 reports, we found that the success rate for fungal infection treatment increased significantly at
 VRCZ levels greater than 1.0&amp;nbsp;μg/ml when a graded cutoff value within the range of 1.0–3.0&amp;nbsp;μg/ml was used as the VRCZ trough
 blood concentra...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5583563</comments>
            <pubDate>Tue, 10 Jan 2012 06:42:05 +0100</pubDate>
            <guid isPermaLink="false">5583563</guid>        </item>
        <item>
            <title>Unusual presentation of neurobrucellosis: a solitary intracranial mass lesion mimicking a cerebral tumor</title>
            <link>http://www.medworm.com/index.php?rid=5583564&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh0062t48816525t0%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Among the diverse presentations of neurobrucellosis, solitary intracranial mass lesions are extremely rare. To the best of
 our knowledge, we describe here the second case of neurobrucellosis mimicking a cerebral tumor caused by Brucella melitensis. The mass lesion was clinically and radiologically indistinguishable from a brain tumor. The diagnosis was established by
 isolating Brucella melitensis in a blood culture and a positive Wright’s agglutination test on the cerebrospinal fluid at 1:320&amp;nbsp;titers. Paraffin sections
 of the cerebral mass showed nongranulomatous encephalitis. We suggest that patients with an isolated intraparenchymal mass
 lesion with nongranulomatous encephalitis should also be studied for brucellosis in endemic areas.
 
 
	Content Type Journ...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5583564</comments>
            <pubDate>Tue, 10 Jan 2012 06:42:04 +0100</pubDate>
            <guid isPermaLink="false">5583564</guid>        </item>
        <item>
            <title>Acute bacterial prostatitis: how to prevent and manage chronic infection?</title>
            <link>http://www.medworm.com/index.php?rid=5572835&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fkp1454304l341854%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We conducted a retrospective analysis of acute bacterial prostatitis (ABP) to evaluate the factors of progressing to chronic
 infection and chronic pelvic pain syndrome IIIa (CPPS IIIa) from ABP. The clinical records of 480 cases compatible with a
 confirmed diagnosis of ABP from five urological centers between 2001 and 2010 were reviewed. We defined chronic infection
 (CI) as a progression to chronic bacterial prostatitis (II), epididymo-orchitis, and showing persistent pyuria and bacteriuria
 after treatment of ABP in admission periods when followed up at 3&amp;nbsp;months or more. Results were analyzed according to two categories:
 category I, developed to CI (group A, n&amp;nbsp;=&amp;nbsp;49) versus recovered without CI or CPPS IIIa (group C, n&amp;nbsp;=&amp;nbsp;385); and category I...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5572835</comments>
            <pubDate>Wed, 04 Jan 2012 06:57:35 +0100</pubDate>
            <guid isPermaLink="false">5572835</guid>        </item>
        <item>
            <title>In vivo efficacy and pharmacokinetics of biapenem in a murine model of ventilator-associated pneumonia with Pseudomonas aeruginosa</title>
            <link>http://www.medworm.com/index.php?rid=5572836&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3203325q844nqjt5%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Biapenem (BIPM) has high bactericidal activity against Pseudomonas aeruginosa and similar activity in vitro as meropenem (MEPM). We used a murine model to examine the efficacy of biapenem against ventilator-associated
 pneumonia (VAP) caused by P. aeruginosa. Mice were treated by intraperitoneal injection with 100&amp;nbsp;mg/kg BIPM or MEPM every 12&amp;nbsp;h beginning 12&amp;nbsp;h after inoculation with
 P. aeruginosa. Survival was evaluated for 7&amp;nbsp;days, and 24&amp;nbsp;h after infection, lung histopathology was analyzed and the number of viable bacteria
 in the lungs and blood was counted. In addition, the pharmacokinetics of BIPM and MEPM were analyzed after the initial treatment.
 BIPM and MEPM significantly prolonged survival compared to control (P&amp;nbsp;&amp;lt;&amp;nbsp;0.05). The...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5572836</comments>
            <pubDate>Wed, 04 Jan 2012 06:57:33 +0100</pubDate>
            <guid isPermaLink="false">5572836</guid>        </item>
        <item>
            <title>Antibodies against mumps virus component proteins</title>
            <link>http://www.medworm.com/index.php?rid=5572837&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fjt82714v2v788530%2F</link>
            <description>In this study, immunofluorescent (IF) antibodies against nucleocapsid (N), fusion (F), and
 hemagglutinin–neuraminidase (HN) proteins were investigated in comparison with NT and EIA antibodies. The antibody against
 N protein was dominant in serum samples obtained from patients with a previous history of mumps infection. Titers of antibodies
 against F and HN proteins were very low. Many serum samples were positive for EIA but negative for NT, and no significant
 correlation was noted between NT and EIA antibodies. Among the three component proteins, correlation of EIA and IF antibodies
 with N protein was relatively good. After vaccination with mumps vaccine, EIA positivity was closely related to the IF antibodies
 against N protein, and after vaccination NT-positive sera became positiv...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5572837</comments>
            <pubDate>Wed, 04 Jan 2012 06:57:32 +0100</pubDate>
            <guid isPermaLink="false">5572837</guid>        </item>
        <item>
            <title>Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period</title>
            <link>http://www.medworm.com/index.php?rid=5553094&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj65048kt724x1110%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;There are a few recent reports about the relationship between the clinical effect and drug-sensitivity test. We investigated
 the relationship between the clinical efficacy of treatment for pulmonary Mycobacterium avium complex (MAC) and drug-sensitivity test for isolated MAC by comparison between data from 2005 to 2007 and from 2008 to 2010.
 We studied 60 patients who satisfied diagnostic criteria of nontuberculous mycobacterial infection established by the American
 Thoracic Society in 2007 and who received combination therapy using rifampicin (RFP), ethambutol (EB), streptomycin (SM),
 and clarithromycin (CAM). Average CAM dosage was increased from the early (517&amp;nbsp;mg/day) to the later (800&amp;nbsp;mg/day) period. Sputum
 conversion rate increased from 63% in the ea...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5553094</comments>
            <pubDate>Wed, 28 Dec 2011 16:53:04 +0100</pubDate>
            <guid isPermaLink="false">5553094</guid>        </item>
        <item>
            <title>Improvement in urinary retention due to recurrent anastomotic prostate cancer treated with various therapies by intra-arterial infusion of cisplatin and ifosfamide</title>
            <link>http://www.medworm.com/index.php?rid=5553095&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F95247qq408680434%2F</link>
            <description>We report a patient who improved following intra-arterial infusion of cisplatin (CDDP) and ifosfamide (IFM) to
 treat urinary retention caused by locally recurring HRPC. After chemotherapy, cancer volume was remarkably reduced and symptoms
 improved.
 
 
	Content Type Journal ArticleCategory Case ReportPages 1-3DOI 10.1007/s10156-011-0352-9Authors
		Keiichiro Uemura, Department of Urology, Kurume University School of Medicine, Asahimach 67, Kurume, Fukuoka, JapanKiyoaki Nishihara, Department of Urology, Kurume University School of Medicine, Asahimach 67, Kurume, Fukuoka, JapanTokumasa Hayashi, Department of Urology, Kurume University School of Medicine, Asahimach 67, Kurume, Fukuoka, JapanKatsuro Tomiyasu, Department of Urology, Kurume University School of Medicine, Asahimach 67, Kurume, F...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5553095</comments>
            <pubDate>Tue, 27 Dec 2011 16:51:16 +0100</pubDate>
            <guid isPermaLink="false">5553095</guid>        </item>
        <item>
            <title>An evaluation of SNP-based PCR methods for the detection of β-lactamase-negative ampicillin-resistant Haemophilus influenzae</title>
            <link>http://www.medworm.com/index.php?rid=5553096&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg882715h0m257427%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Forty-four previously characterized strains of Haemophilus influenzae were used to evaluate the specificity of previously published SNP PCR primers for the detection of the N526K substitution
 in PBP3 of BLNAR isolates using real-time PCR. Hasegawa et al. primers that amplify strains without a substitution at 526
 and fail to amplify strains with N526K were 100% sensitive and specific for detecting N526K. However, primer sets of Hasegawa
 et al. and Nakamura et al. designed to amplify strains with N526K, but not strains without a substitution, were unable to
 do this reliably because the primers were specific for N526K encoded by AAG and failed to amplify strains with N526K encoded
 by AAA. A review of N526K strains deposited on GenBank revealed an even distribution of ...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5553096</comments>
            <pubDate>Tue, 27 Dec 2011 16:51:15 +0100</pubDate>
            <guid isPermaLink="false">5553096</guid>        </item>
        <item>
            <title>Persistence of pandemic influenza H1N1 virus in young patients after oseltamivir therapy in the 2009–2010 season: a comparison with seasonal H1N1 with or without H275Y mutation</title>
            <link>http://www.medworm.com/index.php?rid=5545249&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu34w6q2054000528%2F</link>
            <description>In conclusion, oseltamivir was effective
 for fever and other clinical symptoms; however, the virus persisted longer than expected after treatment in H1N1pdm influenza-infected
 children in the 2009–2010 season, similar to seasonal H1N1 with H275Y mutation in the 2008–2009 season.
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-7DOI 10.1007/s10156-011-0314-2Authors
		Naoki Kawai, Japan Physicians Association, Tokyo Medical Association Building 3F, 2-5 Kanda-Surugadai, Chiyoda-ku, Tokyo, 101-0062 JapanHideyuki Ikematsu, Japan Physicians Association, Tokyo Medical Association Building 3F, 2-5 Kanda-Surugadai, Chiyoda-ku, Tokyo, 101-0062 JapanNorio Iwaki, Japan Physicians Association, Tokyo Medical Association Building 3F, 2-5 Kanda-Surugadai, Chiyoda-ku, Tokyo, 101-0062...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5545249</comments>
            <pubDate>Thu, 22 Dec 2011 12:50:52 +0100</pubDate>
            <guid isPermaLink="false">5545249</guid>        </item>
        <item>
            <title>Performance evaluation of detecting adenovirus by using rapid diagnostic kits among Japanese people</title>
            <link>http://www.medworm.com/index.php?rid=5516091&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fdq7734v088232lh1%2F</link>
            <description>This study evaluated the diagnostic performance of detecting adenovirus by rapid diagnostic kits among Japanese people. A
 meta-analysis was conducted to pool the sensitivity, specificity, positive and negative likelihood ratios, and diagnostic
 odds ratio of immunochromatography methods and latex agglutination tests; enzyme-linked immunosorbent assay tests had already
 been evaluated in another meta-analysis, and no other diagnostic kits have been appropriately studied. Immunochromatography
 methods were shown to have sufficiently high diagnostic power, regardless of whether conjunctiva or throat swabs, or stool
 specimens were sampled, based upon the area under the curve (0.961–0.991); this was significantly higher than enzyme-linked
 immunosorbent assay tests when sampling conjunctiva...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5516091</comments>
            <pubDate>Fri, 16 Dec 2011 06:54:31 +0100</pubDate>
            <guid isPermaLink="false">5516091</guid>        </item>
        <item>
            <title>Brucellar testicular abscess: a rare cause of testicular mass</title>
            <link>http://www.medworm.com/index.php?rid=5516092&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F45186g3386487370%2F</link>
            <description>We report a case of brucellar testicular abscess treated with medical therapy only. Although the patient recovered clinically
 at the end of 6&amp;nbsp;weeks, the regression of the testicular lesion could not be observed until after 5&amp;nbsp;months.
 
 
	Content Type Journal ArticleCategory Case ReportPages 1-4DOI 10.1007/s10156-011-0354-7Authors
		Mucahit Yemisen, Department of Infectious Diseases and Clinical Microbiology, Balikligol State Hospital, 34303 Sanliurfa, TurkeyEkrem Karakas, Department of Radiology, Sanliurfa State Hospital, Sanliurfa, TurkeyIsmail Ozdemir, Department of Urology, Sanliurfa State Hospital, Sanliurfa, TurkeyOmer Karakas, Department of Radiology, Sanliurfa State Hospital, Sanliurfa, Turkey
	

	
		Journal Journal of Infection and ChemotherapyOnline ISSN 1437-7780Print ...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5516092</comments>
            <pubDate>Wed, 14 Dec 2011 16:41:15 +0100</pubDate>
            <guid isPermaLink="false">5516092</guid>        </item>
        <item>
            <title>Super-sticky familial infections caused by Panton–Valentine leukocidin-positive ST22 community-acquired methicillin-resistant Staphylococcus aureus in Japan</title>
            <link>http://www.medworm.com/index.php?rid=5506208&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm15371g273417733%2F</link>
            <description>In this study, we describe a long-term familial infection cluster caused by novel
 PVL-positive CA-MRSA, which most probably originated from India. This MRSA persisted in related families for more than 2&amp;nbsp;years
 with colonization of, for example, the nares and cheek. At least 6 of 12 members (50%) developed deep cutaneous abscesses,
 including recurrent and multifocal abscesses, every 1.2&amp;nbsp;months on average. All MRSA isolates from colonization and abscesses
 were the same, albeit with a variant in pulsed-field gel electrophoresis analysis. The MRSA exhibited the genotype ST22/spa113(t005)/SCCmecIVa/coagulase gene (coa) novel type and strong hemolysis activity. Moreover, the MRSA exhibited high biofilm formation (which was markedly enhanced
 by sub-MICs of oxacillin). Some patients ...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5506208</comments>
            <pubDate>Mon, 12 Dec 2011 06:33:02 +0100</pubDate>
            <guid isPermaLink="false">5506208</guid>        </item>
        <item>
            <title>Recurrent bacterial meningitis by three different pathogens in an isolated asplenic child</title>
            <link>http://www.medworm.com/index.php?rid=5488013&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe1566j53v278n05n%2F</link>
            <description>We describe a girl with ICA who developed recurrent meningitis by three different
 pathogens. The first, meningitis by Escherichia coli, occurred 4&amp;nbsp;days after premature birth. The other two pathogens were serotype 6B Streptococcus
 pneumoniae and Haemophilus influenzae type b (Hib), at 18 and 25&amp;nbsp;months of age, respectively. The patient was successfully treated with prompt antimicrobial therapy
 in all episodes. Serum anti-polyribosylribitol phosphate (PRP) and anti-6B-type pneumococcal antibodies were below the levels
 for protective activity after natural infections. Although anti-PRP antibody was significantly increased after Hib vaccination,
 two (6B and 19F) of seven serotype-specific pneumococcal antibodies were not elevated to protective levels after the second
 7-valent pn...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5488013</comments>
            <pubDate>Tue, 06 Dec 2011 17:03:18 +0100</pubDate>
            <guid isPermaLink="false">5488013</guid>        </item>
        <item>
            <title>A case study of measles vaccination for university students during the measles outbreak in Tokyo, Japan, 2007</title>
            <link>http://www.medworm.com/index.php?rid=5477490&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F98r21527618r6168%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In April 2007, seven students belonging to the same class at Teikyo University developed measles. To prevent the spread of
 infection, 27 of 106 students in the same class who had low anti-measles antibody titers as measured by hemagglutination inhibition
 (HI) assay were vaccinated. After the outbreak had subsided, the HI values were investigated in 103 students, and they answered
 questionnaires about their health condition during the period of the outbreak and their previous clinical histories of measles,
 including vaccination records. There was no new case of measles after introduction of the vaccination program. However, the
 HI titers of 42% of the students who were not vaccinated in this program were significantly elevated. Fever and catarrhal
 signs occurred in...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477490</comments>
            <pubDate>Fri, 02 Dec 2011 06:46:07 +0100</pubDate>
            <guid isPermaLink="false">5477490</guid>        </item>
        <item>
            <title>Fungemia due to Rhodotorula mucilaginosa in an immunocompetent, critically ill patient</title>
            <link>http://www.medworm.com/index.php?rid=5477491&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy795k4496x715697%2F</link>
            <description>We present a case report of fungemia due to R. mucilaginosa in an immunocompetent, critically ill patient, with good evolution with catheter removal and fluconazole therapy. We briefly
 review the spectrum of infections due to R. mucilaginosa and the management of bloodstream infections due to this yeast.
 
 
	Content Type Journal ArticleCategory Case ReportPages 1-3DOI 10.1007/s10156-011-0347-6Authors
		Jesús Monterrubio Villar, Intensive Care Unit, Hospital Don Benito-Villanueva, Carretera Don Benito-Villanueva Km3 s/n., 06400, Don Benito, Badajoz, SpainCarmen González Velasco, Microbiology Service, Hospital Don Benito-Villanueva, Badajoz, SpainJuan Diego Jiménez Delgado, Intensive Care Unit, Hospital Don Benito-Villanueva, Carretera Don Benito-Villanueva Km3 s/n., 06400, Don Benito, ...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477491</comments>
            <pubDate>Wed, 30 Nov 2011 18:42:45 +0100</pubDate>
            <guid isPermaLink="false">5477491</guid>        </item>
        <item>
            <title>A new staphylococcal cassette chromosome mec IV encoding a novel cell-wall-anchored surface protein in a major ST8 community-acquired methicillin-resistant Staphylococcus aureus clone in Japan</title>
            <link>http://www.medworm.com/index.php?rid=5477492&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp3v9g2m1v2256r25%2F</link>
            <description>This study demonstrates a new SCCmecIV encoding a novel CWASP, which could contribute to community spread as a potential colonization factor. Because ST8 CA-MRSA
 with SCCmecIVl causes skin and soft tissue infections and occasionally invasive infections, surveillance is needed.
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-9DOI 10.1007/s10156-011-0348-5Authors
		Yasuhisa Iwao, Division of Bacteriology, Department of Infectious Disease Control and International Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, JapanTomomi Takano, Division of Bacteriology, Department of Infectious Disease Control and International Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, JapanWataru Higuchi, Division of Bacte...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477492</comments>
            <pubDate>Wed, 30 Nov 2011 18:42:44 +0100</pubDate>
            <guid isPermaLink="false">5477492</guid>        </item>
        <item>
            <title>Bactericidal effects of antimicrobial agents on epithelial cell-associated Pseudomonas aeruginosa</title>
            <link>http://www.medworm.com/index.php?rid=5450115&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7777225750180173%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;It is not clear whether antipseudomonal agents can kill cell-associated bacteria within a short time. Madin–Darby canine kidney
 (MDCK) and A549 cells were infected with Pseudomonas aeruginosa ATCC 27853 and PAO1 and the bactericidal activity of ceftazidime, imipenem, meropenem, gentamicin, and ciprofloxacin against
 the organisms was investigated. In both MDCK and A549 cells, β-lactams could not kill epithelial cell-associated bacteria
 within 2&amp;nbsp;h. Gentamicin at concentrations ≤32&amp;nbsp;μg/ml killed more than 99% of epithelial cell-associated bacteria. Ciprofloxacin
 at 0.5&amp;nbsp;μg/ml killed more than 99.9% of MDCK cell-associated bacteria. Ciprofloxacin has the strongest and most rapid bactericidal
 activity against epithelial cell-associated bacteria, whic...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5450115</comments>
            <pubDate>Thu, 24 Nov 2011 17:52:22 +0100</pubDate>
            <guid isPermaLink="false">5450115</guid>        </item>
        <item>
            <title>Clinical characteristics of healthcare-associated pneumonia in a public hospital in a metropolitan area of Japan</title>
            <link>http://www.medworm.com/index.php?rid=5450116&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn65063m72u0278t1%2F</link>
            <description>In conclusion, patients with HCAP have different epidemiological characteristics
 compared with those with CAP in a metropolitan area of Japan. Outcomes and risk factors for mortality of patients with HCAP
 included poor nutritional status and high severity scores on the pneumonia severity scoring system.
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-9DOI 10.1007/s10156-011-0344-9Authors
		Midori Sugisaki, Department of Respiratory Medicine, Tokyo Metropolitan Hiroo General Hospital, 2-34-10 Ebisu, Shibuya-ku, Tokyo, 150-0013 JapanTatsuji Enomoto, Department of Respiratory Medicine, Tokyo Metropolitan Hiroo General Hospital, 2-34-10 Ebisu, Shibuya-ku, Tokyo, 150-0013 JapanYasuhiro Shibuya, Department of Infectious Diseases, Tokyo Metropolitan Hiroo General Hospital, Tok...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5450116</comments>
            <pubDate>Thu, 24 Nov 2011 17:52:21 +0100</pubDate>
            <guid isPermaLink="false">5450116</guid>        </item>
        <item>
            <title>In vitro antichlamydial activity of garenoxacin against Chlamydia trachomatis</title>
            <link>http://www.medworm.com/index.php?rid=5450117&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1l39023353n12234%2F</link>
            <description>In conclusion,
 garenoxacin is expected to be a useful quinolone in the treatment of infectious diseases caused by C. trachomatis.
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-8DOI 10.1007/s10156-011-0345-8Authors
		Naoko Futakuchi, Research Laboratories, Toyama Chemical Co., Ltd, 2-4-1 Shimookui, Toyama, 930-8508 JapanMasatoshi Nakatani, Research Laboratories, Toyama Chemical Co., Ltd, 2-4-1 Shimookui, Toyama, 930-8508 JapanMasahiro Takahata, Research Laboratories, Toyama Chemical Co., Ltd, 2-4-1 Shimookui, Toyama, 930-8508 JapanJunichi Mitsuyama, Research Laboratories, Toyama Chemical Co., Ltd, 2-4-1 Shimookui, Toyama, 930-8508 Japan
	

	
		Journal Journal of Infection and ChemotherapyOnline ISSN 1437-7780Print ISSN 1341-321X (Source: Journal of Infection and Chemoth...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5450117</comments>
            <pubDate>Thu, 24 Nov 2011 06:50:27 +0100</pubDate>
            <guid isPermaLink="false">5450117</guid>        </item>
        <item>
            <title>Encephalopathy, disseminated intravascular coagulation, and hemolytic–uremic syndrome after infection with enterohemorrhagic Escherichia coli O111</title>
            <link>http://www.medworm.com/index.php?rid=5409737&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg47166607u402628%2F</link>
            <description>In conclusion, EHEC O111 can cause severe illness in children and adults, and
 the prognosis becomes poorer as the severity of complications increases. Close monitoring including platelet counts and LDH
 are useful. Once these clinical parameters change, intensive treatment should be provided to prevent the development of severe
 complications.
 
 
	Content Type Journal ArticleCategory Case ReportPages 1-7DOI 10.1007/s10156-011-0336-9Authors
		Sadaya Matano, Infection Control Unit, Tonami General Hospital, Tonami, Toyama 939-1395, JapanKatsuhisa Inamura, Department of Gastroenterology, Tonami General Hospital, Tonami, Toyama 939-1395, JapanMichio Konishi, Department of Pediatrics, Tonami General Hospital, Tonami, Toyama 939-1395, JapanToshiya Okumura, Department of Nephrology, Tonami Gener...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5409737</comments>
            <pubDate>Mon, 14 Nov 2011 06:35:14 +0100</pubDate>
            <guid isPermaLink="false">5409737</guid>        </item>
        <item>
            <title>Iliopsoas abscess caused by Aspergillus fumigatus complicated by pulmonary aspergillosis</title>
            <link>http://www.medworm.com/index.php?rid=5409738&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7782p3n2641480vx%2F</link>
            <description>We report a case of iliopsoas abscess caused by Aspergillus fumigatus with pulmonary complications. A 60-year-old man was admitted to the Showa University Hospital Department of Gastroenterology
 with fulminant hepatitis B on April 14, 2010, and treated with steroids. Although fulminant hepatitis B was improved by steroid
 and symptomatic therapy, he developed a fever on hospital day 39. The chest X-ray film showed a nodular lesion in the right
 middle-lower lung field, and both the (1&amp;nbsp;→&amp;nbsp;3)-β-d-glucan and Candida mannan antigen tests were positive. The β-d-glucan level increased despite treatment with fluconazole and other drugs, including low-dose micafungin. Abdominal computed
 tomography showed a low-density area in the right iliopsoas muscle. He was then referred to the D...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5409738</comments>
            <pubDate>Mon, 14 Nov 2011 06:35:13 +0100</pubDate>
            <guid isPermaLink="false">5409738</guid>        </item>
        <item>
            <title>Urosepsis caused by Globicatella sanguinis and Corynebacterium riegelii in an adult: case report and literature review</title>
            <link>http://www.medworm.com/index.php?rid=5409740&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg17w325105g86q70%2F</link>
            <description>We report an extremely rare case of urosepsis caused by Globicatella sanguinis and Corynebacterium riegelii coinfection in a 94-year-old Japanese man with nephrolithiasis. Prompt identification of this coinfection is important so
 that effective antimicrobial coverage can be initiated.
 
 
	Content Type Journal ArticleCategory Case ReportPages 1-3DOI 10.1007/s10156-011-0335-xAuthors
		Masatoshi Matusnami, Department of General Internal Medicine and Infectious Diseases, Kameda Medical Center, 929 Higashi-cho, Kamogawa, Chiba 296-8602, JapanYoshihito Otsuka, Department of Laboratory Medicine, Kameda Medical Center, Kamogawa, JapanKiyofumi Ohkusu, Department of Microbiology, Gifu University Graduate School of Medicine, Gifu, JapanMisa Sogi, Department of General Internal Medicine and Infectio...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5409740</comments>
            <pubDate>Fri, 11 Nov 2011 12:48:32 +0100</pubDate>
            <guid isPermaLink="false">5409740</guid>        </item>
        <item>
            <title>Complementation of the exoS gene in the pvdE pyoverdine synthesis gene-deficient mutant of Pseudomonas aeruginosa results in recovery of the pvdE gene-mediated penetration through the intestinal epithelial cell barrier but not the pvdE-mediated virulence in silkworms</title>
            <link>http://www.medworm.com/index.php?rid=5409739&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq6130q131g2p4r8q%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Translocation of endogenous Pseudomonas aeruginosa from the colonized intestinal tract is an important pathogenic phenomenon. Comparative genome hybridization analysis of high
 virulent and low virulent strains allowed us to identify bacterial genes that are associated with bacterial translocation
 from gut in infected hosts. Here we focused on the pvdE pyoverdine synthesis gene among the identified bacterial genes, showing that the pvdE gene is required for bacterial penetration through epithelial cell monolayers and for bacterial translocation from gut to
 hemolymph in infected silkworms. We next revealed that mRNA expression level of the exoS gene in a pvdE-deficient mutant (ΔpvdE) after incubation with Caco-2 cells was greatly reduced as compared with that in the w...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5409739</comments>
            <pubDate>Fri, 11 Nov 2011 12:48:32 +0100</pubDate>
            <guid isPermaLink="false">5409739</guid>        </item>
        <item>
            <title>Necrotizing fasciitis following psoas muscle abscess caused by hypermucoviscous Klebsiella pneumoniae</title>
            <link>http://www.medworm.com/index.php?rid=5409741&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp822g25l765740xn%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A 59-year-old Japanese diabetic woman was admitted to a small private hospital with general malaise, fever, and a 1-month
 history of low back pain. A computed tomography scan of the abdomen revealed left abdominal necrotizing fasciitis with suspected
 left psoas muscle abscess. She was transferred to Gunma University Hospital, received antibiotic therapy, and underwent debridement
 of the infected subcutaneous tissue, fascia, and necrotic left psoas muscle. She was transferred to the intensive care unit
 to receive mechanical ventilation and inotropic support. Blood culture showed growth of Klebsiella pneumoniae, from which hypermucoviscosity was detected by the string test. She was extubated on day 5 of hospitalization and transferred
 to a general ward on day 14. Fre...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5409741</comments>
            <pubDate>Tue, 08 Nov 2011 06:50:25 +0100</pubDate>
            <guid isPermaLink="false">5409741</guid>        </item>
        <item>
            <title>Evaluation of teicoplanin dosing designs to achieve a new target trough concentration</title>
            <link>http://www.medworm.com/index.php?rid=5409742&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn453755071q5h533%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Minimum inhibitory concentration (MIC) creep in vancomycin has prompted guidelines that recommend a target trough concentration
 (C
 min) of 15–20&amp;nbsp;mg/L, and it is also considered necessary to set a C
 min of &amp;gt;15&amp;nbsp;mg/L for teicoplanin (TEIC), especially in patients with complicated methicillin-resistant Staphylococcus aureus (MRSA) infections. The aim of this study was to investigate the appropriate TEIC regimen for reaching the revised target
 C
 min (15–30&amp;nbsp;mg/L) in patients with normal renal function and those with renal dysfunction. We analyzed patients with MRSA infections
 who were treated with TEIC between July 2006 and December 2009. Two-day loading regimen was studied in patients with non-renal-dysfunction
 (group 1). The 1-day loading regime...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5409742</comments>
            <pubDate>Tue, 08 Nov 2011 06:50:24 +0100</pubDate>
            <guid isPermaLink="false">5409742</guid>        </item>
        <item>
            <title>Comparative molecular and microbiological diagnosis of 19 infective endocarditis cases in which causative microbes were identified by PCR-based DNA sequencing from the excised heart valves</title>
            <link>http://www.medworm.com/index.php?rid=5389017&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F65472185g37tl018%2F</link>
            <description>In this study, we analyzed 19 valve samples from patients with confirmed IE, as identified
 by Duke’s criteria. Using broad-range PCR amplification, followed by direct gene sequencing, pathological agents were identified
 in all samples. Although blood cultures yielded negative results in 4 cases, PCR analysis of valve samples showed positive
 identification of causative organisms. In 3 cases, there was a difference between blood culture and PCR in identification
 of pathological agents, which are likely to be misidentified by the conventional method based on the phenotypic database.
 Postoperative antibiotics were chosen considering the severity of lesions and the results of PCR, Gram staining, and valve
 cultures. All patients were cured without relapse. The broad-range PCR method was ...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389017</comments>
            <pubDate>Tue, 01 Nov 2011 16:51:23 +0100</pubDate>
            <guid isPermaLink="false">5389017</guid>        </item>
        <item>
            <title>Severe pneumococcal community-acquired pneumonia admitted to medical Tunisian ICU</title>
            <link>http://www.medworm.com/index.php?rid=5389020&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5r42m2nu71gk1277%2F</link>
            <description>In conclusion, pneumococcal CAP requiring hospitalization in
 the ICU is associated with high mortality. All isolated stains were susceptible to penicillin.
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-8DOI 10.1007/s10156-011-0337-8Authors
		Khairallah Belkhouja, Department of Intensive Care Medicine, Abderrahmen Mami Hospital, Ariana, TunisiaKaïs Ben Romdhane, Department of Intensive Care Medicine, Abderrahmen Mami Hospital, Ariana, TunisiaAsma Ghariani, Department of Microbiology, Abderrahmen Mami Hospital, Ariana, TunisiaAfef Hammami, Department of Intensive Care Medicine, Abderrahmen Mami Hospital, Ariana, TunisiaEmna M’hiri, Department of Microbiology, Abderrahmen Mami Hospital, Ariana, TunisiaLeila Slim-Saidi, Department of Microbiology, Abderrahmen Mami Hospi...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389020</comments>
            <pubDate>Tue, 01 Nov 2011 16:51:22 +0100</pubDate>
            <guid isPermaLink="false">5389020</guid>        </item>
        <item>
            <title>Paradoxical roles of alveolar macrophages in the host response to Cryptococcus neoformans</title>
            <link>http://www.medworm.com/index.php?rid=5389019&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd3n177u5p1007873%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;
 Cryptococcus neoformans (Cn) is a fungal pathogen that is a serious health threat to immunocompromised individuals. Upon environmental exposure, infectious
 fungal propagules are inhaled into the host’s lungs. The anticryptococcal actions of alveolar macrophages (AM), the predominant
 host phagocyte of the innate immune system in the lungs, are fundamental in determining whether containment and clearance
 of the pathogen occurs by the development of an adapted immune response or whether infection is established and progresses
 to disease. However, the fungus is also capable of surviving the antimicrobial actions of AM and exploits these host phagocytes
 to establish infection and exacerbate disease. In addition, there is evidence suggesting that cryptococcosis may o...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389019</comments>
            <pubDate>Tue, 01 Nov 2011 16:51:22 +0100</pubDate>
            <guid isPermaLink="false">5389019</guid>        </item>
        <item>
            <title>Adalimumab treatment may replace or enhance the activity of steroids in steroid-refractory tuberculous meningitis</title>
            <link>http://www.medworm.com/index.php?rid=5389018&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fmh60547712q4vvj7%2F</link>
            <description>We describe a paradoxical response involving the central nervous system in a patient with steroid-refractory tuberculous meningitis
 that was unresponsive to systemic corticosteroids but was improved with adalimumab. The immunomodulatory effect of tumor necrosis
 factor inhibitors may have a role in replacing or enhancing the activity of steroids in the management of steroid-refractory
 tuberculous meningitis.
 
 
	Content Type Journal ArticleCategory Case ReportPages 1-3DOI 10.1007/s10156-011-0334-yAuthors
		Ho-Su Lee, Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, 388-1 Poonganp dong, Songpa-gu, Seoul, 138-736 Republic of KoreaYumi Lee, Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, 388-1 ...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389018</comments>
            <pubDate>Tue, 01 Nov 2011 16:51:22 +0100</pubDate>
            <guid isPermaLink="false">5389018</guid>        </item>
        <item>
            <title>Usefulness of linezolid in the treatment of hospital-acquired pneumonia caused by MRSA: a prospective observational study</title>
            <link>http://www.medworm.com/index.php?rid=5389021&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F364l528762v30640%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Clinical results for linezolid (LZD) treatment of hospital-acquired pneumonia (HAP) caused by methicillin-resistant Staphylococcus aureus (MRSA), particularly microbiologically evaluable or severe cases, are limited in Japan. A prospective observational study
 was conducted in order to assess the usefulness of LZD in Japanese patients with MRSA pneumonia. The study tracked fifteen
 participants treated with LZD for pneumonia who met the criteria of the HAP guidelines and were confirmed to have pneumonia
 caused by MRSA. Of these, six were severe and 13 had received antibiotic treatment before treatment with LZD. Of the 13 participants
 assessed for their clinical responses, seven were rated as cures, three were rated as failures, and three were indeterminate.
 The overa...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389021</comments>
            <pubDate>Mon, 31 Oct 2011 17:01:39 +0100</pubDate>
            <guid isPermaLink="false">5389021</guid>        </item>
        <item>
            <title>Apoptosis of bladder cancer by sodium butyrate and cisplatin</title>
            <link>http://www.medworm.com/index.php?rid=5389022&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2wg0667123q68717%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The effects of sodium butyrate (SB), a histone deacetylase inhibitor, in combination with cisplatin (CDDP), for inhibition
 of cell growth and induction of apoptosis were investigated in bladder cancer cell lines in vitro. Bladder cancer cell lines
 T24, 253J, and UMUC3 were treated with different concentrations of CDDP or SB. Cell proliferation was studied by XTT assay.
 Cell-cycle analysis and induction of apoptosis were analyzed by laser scanning cytometry (LSC). Western blot analysis was
 used to determine expression of p21, p27, TRADD, FADD, caspase-2, and caspase-7. We observed that SB in combination with CDDP
 induced significant inhibition of cell growth in a dose-dependent manner through G1 arrest and apoptosis, as determined by LSC. When bladder cancer cell li...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389022</comments>
            <pubDate>Mon, 31 Oct 2011 17:01:38 +0100</pubDate>
            <guid isPermaLink="false">5389022</guid>        </item>
        <item>
            <title>Genotyping of Haemophilus influenzae type b in pre-vaccination era</title>
            <link>http://www.medworm.com/index.php?rid=5362799&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft2k3785w527r4t50%2F</link>
            <description>This study was conducted between January
 2008 and August 2011 as part of a birth cohort study in Sado Island, Japan, to elucidate the prevalence of Hib and its clones
 in a specific region. Nasopharyngeal cultures were obtained from 349 subjects at 4-, 7-, 10-, 18-, and 36-month health checkups
 and analyzed for H. influenzae. The Hib and nontypeable H. influenzae detection rates ranged from 0 to 1.5% (12 isolates) and from 7.9 to 32.9%, respectively. Twelve pediatric patients diagnosed
 with invasive or non-invasive Hib infections during the study period were also enrolled. The Hib isolates were analyzed for
 carriage of the beta-lactamase gene and ftsI mutations, and multilocus sequence type (MLST, ST type). Of the 24 Hib isolates, 18 (75%) were ST54, 5 (21%) were ST190,
 and 1 isolate ...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5362799</comments>
            <pubDate>Fri, 28 Oct 2011 17:11:16 +0100</pubDate>
            <guid isPermaLink="false">5362799</guid>        </item>
        <item>
            <title>Vigorous cleaning and adequate ventilation are necessary to control an outbreak in a neonatal intensive care unit</title>
            <link>http://www.medworm.com/index.php?rid=5362798&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj511237g57753711%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;An outbreak of Bacillus cereus (B. cereus) bacteremia occurred in our neonatal intensive care unit (NICU) in July 2005. Many strains of B. cereus were cultured from patient specimens, as well as from environmental samples such as the surfaces of instruments and air in
 the NICU. Some of these strains were analyzed by pulsed field gel electrophoresis, and several were confirmed to be identical.
 We speculated that the bacterial load in the environment had initially increased and then possibly spread throughout the NICU
 facility via the airflow of the ventilation system. For this reason, besides maintaining standard precautions, we performed
 a vigorous clean of the NICU, and covered the vents to prevent dust falling from them. These protective measures ended the
 outbre...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5362798</comments>
            <pubDate>Fri, 28 Oct 2011 17:11:16 +0100</pubDate>
            <guid isPermaLink="false">5362798</guid>        </item>
        <item>
            <title>Tuberculous meningitis together with systemic brucellosis</title>
            <link>http://www.medworm.com/index.php?rid=5362800&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2l8267732hn557k0%2F</link>
            <description>We present a case of a 57-year-old woman admitted with findings of meningitis. Cerebrospinal fluid (CSF) tests revealed a
 pleocytosis together with a low CSF glucose concentration. Empirically, antituberculosis treatment was started. Rose Bengal
 and Wright tests were performed to exclude brucellosis with central nervous system involvement. These tests were positive
 in serum but not in CSF. Antibrucellosis treatment with doxycycline and ceftriaxone was started without withdrawing the antituberculosis
 treatment because of the possibility of simultaneous infection with both tuberculosis and brucellosis agents. Finally, this
 approach was shown to be correct when tuberculosis was isolated from the culture of CSF. Clinicians in endemic regions for
 brucellosis should be careful while diagno...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5362800</comments>
            <pubDate>Fri, 28 Oct 2011 06:06:55 +0100</pubDate>
            <guid isPermaLink="false">5362800</guid>        </item>
        <item>
            <title>Heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) emerged before the clinical introduction of vancomycin in Japan: a retrospective study</title>
            <link>http://www.medworm.com/index.php?rid=5362801&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr3300142r8718887%2F</link>
            <description>We report here a retrospective prevalence
 study of VISA and hVISA on 750 MRSA clinical strains isolated from 31 Japanese national university hospitals in 1990, the
 year before the introduction of injectable vancomycin into clinical use in Japan in 1991. No VISA strain was identified, but
 population analysis identified 38 hVISA strains (5.1%) from 19 hospitals. We also determined the nucleotide sequences of vraSR, walRK,
 clpP, and rpoB genes whose mutations are known to be associated with vancomycin resistance. When compared with vancomycin-susceptible MRSA
 strain N315, six of the 38 hVISA strains possessed nonsynonymous mutations in vraSR, seven in walRK, and two in rpoB genes, Thirteen of 38 (34.2%) hVISA strains possessed at least one of these mutations. Results were consistent with...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5362801</comments>
            <pubDate>Fri, 28 Oct 2011 06:06:54 +0100</pubDate>
            <guid isPermaLink="false">5362801</guid>        </item>
        <item>
            <title>Antimicrobial efficacies of several antibiotics against uterine cervicitis caused by Mycoplasma genitalium</title>
            <link>http://www.medworm.com/index.php?rid=5349162&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1j14776463w25276%2F</link>
            <description>In conclusion, AZM-SR 2&amp;nbsp;g single
 dose, MFLX 400&amp;nbsp;mg/day for 14&amp;nbsp;days, and STFX 200&amp;nbsp;mg/day for 14&amp;nbsp;days would each be an effective treatment for M. genitalium infection.
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-5DOI 10.1007/s10156-011-0329-8Authors
		Michinori Terada, Department of Infection Control and Prevention, Aichi Medical University, 21 Karimata, Yazako, Nagakute-cho, Aichi-gun, Aichi, 480-1195 JapanKoji Izumi, Department of Obstetrics and Gynecology, Izumi Ladies Clinic, Gifu, JapanEmiko Ohki, Department of Infection Control and Prevention, Aichi Medical University, 21 Karimata, Yazako, Nagakute-cho, Aichi-gun, Aichi, 480-1195 JapanYuka Yamagishi, Department of Infection Control and Prevention, Aichi Medical University, 21 Karimata, Ya...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5349162</comments>
            <pubDate>Fri, 21 Oct 2011 16:01:27 +0100</pubDate>
            <guid isPermaLink="false">5349162</guid>        </item>
        <item>
            <title>Tuberculous hilar lymphadenopathy progressing after isoniazid administration</title>
            <link>http://www.medworm.com/index.php?rid=5349161&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F97231335147226q2%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Right hilar lymphadenopathy was the only radiologic finding in an immunocompetent 19-year-old man with a positive whole blood
 interferon-γ enzyme-linked immunosorbent test (QuantiFERON-TB-2G). Because his initial treating physician did not notice the
 lung lesion on chest radiography, isoniazid (INH) monotherapy was begun with subsequent progression of the lymphadenopathy.
 We must take into consideration even hilar lymphadenopathy in patients with tuberculosis (TB) disease without detectable Mycobacterium (M.) tuberculosis organisms, because INH monotherapy may result in progression of the TB lesion.
 
 
	Content Type Journal ArticleCategory Case ReportPages 1-4DOI 10.1007/s10156-011-0328-9Authors
		Shuichi Yano, Department of Pulmonary Medicine, National Hospital Or...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5349161</comments>
            <pubDate>Fri, 21 Oct 2011 16:01:27 +0100</pubDate>
            <guid isPermaLink="false">5349161</guid>        </item>
        <item>
            <title>Identification of Legionella pneumophila serogroups and other Legionella species by mip gene sequencing</title>
            <link>http://www.medworm.com/index.php?rid=5349163&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7624365208252wg7%2F</link>
            <description>In this study, we investigated the potential of the mip gene sequence to differentiate isolates of different species of Legionella and different serogroups of Legionella pneumophila. We used 35 clinical L. pneumophila isolates and one clinical isolate each of Legionella micdadei, Legionella longbeachae, and Legionella dumoffii (collected from hospitals all over Japan between 1980 and 2007). We used 19 environmental Legionella anisa isolates (collected in the Okinawa, Nara, Osaka, and Hyogo prefectures between 1987 and 2007) and two Legionella type strains. We extracted bacterial genomic DNA and amplified out the mip gene by PCR. PCR products were purified by agarose gel electrophoresis and the mip gene was then sequenced. The L. pneumophila isolates could be divided into two groups: one gr...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5349163</comments>
            <pubDate>Thu, 20 Oct 2011 15:53:45 +0100</pubDate>
            <guid isPermaLink="false">5349163</guid>        </item>
        <item>
            <title>Methicillin-resistant Staphylococcus aureus bloodstream infections in a Japanese University Hospital between 1987 and 2004</title>
            <link>http://www.medworm.com/index.php?rid=5337396&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy208074288303867%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Methicillin-resistant Staphylococcus aureus (MRSA) infections have been the most common cause of nosocomial infections in Japan, but their genetic characteristics related
 to bloodstream infections have not been well studied. The aim of this study was to investigate a comprehensive molecular characterization
 of MRSA blood isolates during the historical 18-year study period between 1987 and 2004 in a tertiary care university hospital.
 A total of 137 MRSA isolates recovered from the blood of inpatients at Fukuoka University Hospital were analyzed. Clinical
 information and antimicrobial susceptibility profiles were reviewed, and staphylococcal chromosomal cassette mec (SCCmec), accessory gene regulator (agr), and a battery of bacterial genes were tested by PCR-based ass...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5337396</comments>
            <pubDate>Tue, 18 Oct 2011 15:58:46 +0100</pubDate>
            <guid isPermaLink="false">5337396</guid>        </item>
        <item>
            <title>Evaluation of the efficacy and safety of intravenous ciprofloxacin versus meropenem in the treatment of postoperative infection</title>
            <link>http://www.medworm.com/index.php?rid=5337397&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7x2r582j33821n74%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Therapeutic options for postoperative infection in gastrointestinal surgery are limited. To identify new treatment alternatives,
 the Japan Society for Surgical Infection conducted a multicenter prospective, randomized, controlled clinical trial comparing
 the efficacy of intravenous ciprofloxacin (CIP IV) and intravenous meropenem (MEM IV). Between July 2005 and May 2008, the
 trial recruited patients who developed postoperative infection or had suspected infectious systemic inflammatory response
 syndrome after elective clean-contaminated gastrointestinal surgery. All patients had received prophylactic postoperative
 antibiotic treatment. Patients received either intravenous CIP IV 300&amp;nbsp;mg b.i.d. or MEM IV 500&amp;nbsp;mg b.i.d. A total of 205 patients
 from 31 instit...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5337397</comments>
            <pubDate>Tue, 18 Oct 2011 15:58:45 +0100</pubDate>
            <guid isPermaLink="false">5337397</guid>        </item>
        <item>
            <title>The validity of the criteria for primary infection of Chlamydophila pneumoniae in children by measuring ELISA IgM antibodies</title>
            <link>http://www.medworm.com/index.php?rid=5337398&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fek285763907uq672%2F</link>
            <description>In this study, we performed ROC analysis involving 136 pediatric patients with acute airway
 symptoms (0–14&amp;nbsp;years of age), considering a 32-fold or higher micro-immunofluorescence IgM antibody titer against C. pn as positive. Setting the cut-off value for ELISA C. pn IgM antibody ID at 2.0, the specificity was 100%, with no false positivity. The maximum (sensitivity&amp;nbsp;+&amp;nbsp;specificity)/2 was
 obtained when the cut-off value was set at 1.5. Therefore, IgM ID ≥2.0 was regarded as definitely positive and an IgM ID between
 1.5 and 2.0 was regarded as indeterminate as diagnostic criteria for the primary infection. When the prevalence was investigated
 in 3,108 children (0–15&amp;nbsp;years of age) with airway symptoms based on these criteria, 542 cases (17.4%) were positive, and th...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5337398</comments>
            <pubDate>Tue, 18 Oct 2011 15:58:44 +0100</pubDate>
            <guid isPermaLink="false">5337398</guid>        </item>
        <item>
            <title>Enhancement of interleukin-8-induced chemotactic response and reactive oxygen species production in HL-60 cells expressing CXCR1</title>
            <link>http://www.medworm.com/index.php?rid=5337399&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fdw76mu401k3x8552%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Neutrophils play a pivotal role in immunity against infection by ingesting and killing invading microbes. Neutrophils isolated
 from human peripheral blood have been used for a number of studies conducted for evaluation of immunomodulating drugs, cytokines,
 and microbe products. Human promyelocytic leukemia cells, HL-60, have been extensively studied because they can differentiate
 into neutrophil-like cells by addition of all-trans retinoic acid or dimethyl sulfoxide. For a system that would always allow experimental use of granulocytic cells in a uniformly
 activated state, we have established HL-60 cell lines with increased migratory activity by transducing the CXC chemokine receptor
 1 (CXCR1) gene. When these cell lines were primed with CXC chemokine ligand 8 (IL-...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5337399</comments>
            <pubDate>Tue, 18 Oct 2011 15:58:42 +0100</pubDate>
            <guid isPermaLink="false">5337399</guid>        </item>
        <item>
            <title>Neonatal meningitis caused by Streptococcus gallolyticus subsp. pasteurianus</title>
            <link>http://www.medworm.com/index.php?rid=5324731&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk44273k267870425%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We encountered a case of neonatal meningitis caused by Streptococcus gallolyticus subsp. pasteurianus. The patient was an 8-day-old boy. Gram staining of the cerebrospinal fluid (CSF) revealed gram-positive cocci in pairs or
 in short chains. In culture, γ-streptococcus-like colonies grew. The result of 16S rRNA sequence analysis identified S. gallolyticus subsp. pasteurianus. From these results, bacterial meningitis was diagnosed and, as a result of antimicrobial susceptibility testing, single-dose
 ampicillin therapy was given. Because inflammatory deterioration and spread was suspected from the CSF test results, this
 therapy was added by panipenem/betamipron. In response to his recovery, antibiotic treatment was stopped and the boy was discharged.
 This bacterium w...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5324731</comments>
            <pubDate>Fri, 14 Oct 2011 10:39:18 +0100</pubDate>
            <guid isPermaLink="false">5324731</guid>        </item>
        <item>
            <title>Analysis of isolated bacteria and short-term antimicrobial prophylaxis with tazobactam–piperacillin (1:4 ratio) for prevention of postoperative infections after radical cystectomy</title>
            <link>http://www.medworm.com/index.php?rid=5324730&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl7844216487n7076%2F</link>
            <description>This study,
 even though open and noncomparative, showed that a short-interval regimen containing 0.5/2 g TAZ–PIPC provides adequate antimicrobial
 prophylaxis in patients undergoing radical cystectomy.
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-5DOI 10.1007/s10156-011-0317-zAuthors
		Kazushi Tanaka, Division of Urology, Department of Surgery Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunokicho, Chuoku, Kobe, 650-0017 JapanSoichi Arakawa, Division of Urology, Department of Surgery Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunokicho, Chuoku, Kobe, 650-0017 JapanTetsuya Miura, Division of Urology, Department of Surgery Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunokicho, Chuoku, Kobe, 650-0017 JapanKatsumi Sh...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5324730</comments>
            <pubDate>Fri, 14 Oct 2011 10:39:18 +0100</pubDate>
            <guid isPermaLink="false">5324730</guid>        </item>
        <item>
            <title>Disseminated Nocardia farcinica infection in a patient with myasthenia gravis successfully treated by linezolid: a case report and literature review</title>
            <link>http://www.medworm.com/index.php?rid=5324732&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg17823t6352n4852%2F</link>
            <description>In this report, we described a disseminated
 Nocardia farcinica infection that occurred in a patient with myasthenia gravis who suffered from multiple drug allergies and was successfully
 treated using linezolid. We undertook a review of the literature of previously reported cases of nocardiosis treated with
 linezolid. To date, only 15 cases of nocardiosis treated with linezolid have been published. All cases exhibited long-term
 tolerance of linezolid, and 14 of 15 cases showed either an improvement in or complete clearance of the infection. According
 to the literature review, linezolid is an attractive alternative to trimethoprim–sulfamethoxazole for the treatment of disseminated
 nocardiosis, despite limited clinical evidence to support this claim.
 
 
	Content Type Journal ArticleC...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5324732</comments>
            <pubDate>Thu, 13 Oct 2011 15:49:08 +0100</pubDate>
            <guid isPermaLink="false">5324732</guid>        </item>
        <item>
            <title>Disseminated mucormycosis infection after the first course of dose-modified R-EPOCH for advanced-stage lymphoma</title>
            <link>http://www.medworm.com/index.php?rid=5316467&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg664364514k67421%2F</link>
            <description>We report the case of a 63-year-old man who presented at our hospital after experiencing fever and dyspnea for more than 1&amp;nbsp;month.
 Because his general condition was deteriorating, he was referred to our intensive care unit. He needed critical care and was
 treated with vasopressors, artificial ventilation, and continuous hemodialysis. Considering his systemic condition, hematological
 malignancy was suspected. Bone marrow and skin biopsies were performed, and the condition was diagnosed as diffuse large B-cell
 lymphoma. On the 15th day, suspecting infectious lung disease, we performed bronchoscopy, which showed Rhizopus infection. Thus, the patient was administered high-dose liposomal amphotericin B (10&amp;nbsp;mg/kg) therapy. On the 54th day, he
 died of a massive pulmonary hemorrhage....</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5316467</comments>
            <pubDate>Tue, 11 Oct 2011 15:49:48 +0100</pubDate>
            <guid isPermaLink="false">5316467</guid>        </item>
        <item>
            <title>Prevalence of sexually transmitted infections and sexual behavior of young adults and middle-aged people presenting to health examination centers in Korea</title>
            <link>http://www.medworm.com/index.php?rid=5316468&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F071785j353u5x576%2F</link>
            <description>This study investigated prevalence rates of syphilis, gonorrhea, and chlamydia among 1612 persons aged
 20–59&amp;nbsp;years among the general population who visited health examination centers in Korea, and examined the sexual behavior
 of young and middle-aged adults using a questionnaire survey. In total, 807 males and 805 females participated in this study,
 and among the 1612 subjects, 6, 7, and 90 were gave positive results in syphilis, gonorrhea, and chlamydia infection tests,
 respectively, indicating prevalence rates of 0.37, 0.43, and 5.58%. In the questionnaire survey, 85.8% of the respondents
 answered that they had not taken any test for a sexually transmitted infection, and chlamydia-positive respondents were observed
 to have had a significantly higher number of sexual partners...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5316468</comments>
            <pubDate>Tue, 11 Oct 2011 15:49:47 +0100</pubDate>
            <guid isPermaLink="false">5316468</guid>        </item>
        <item>
            <title>Mantle cell lymphoma involvement of the pleura and tuberculous pleurisy with pulmonary tuberculosis: a case report and literature review</title>
            <link>http://www.medworm.com/index.php?rid=5297802&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F84hh571644074718%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A 78-year-old Japanese woman was admitted to our hospital for fever, dry cough, and right pleural effusion. She was diagnosed
 with mantle cell lymphoma (MCL) at 73&amp;nbsp;years of age and was treated with carcinostatics, but MCL was refractory. Chest computed
 tomography (CT) on admission revealed a localized trabecular shadow in the middle lobe of the right lung and right pleural
 effusion with thickened visceral pleura. Right pleural effusion was exudative, lymphocytes were dominant, and adenosine deaminase
 isoenzymes were elevated. 18F-fluorodeoxyglucose positron emission tomography/CT revealed positive findings in the right thickened visceral pleura and
 right middle lobe. We suspected tuberculosis, but bronchoscopy revealed that the washing fluid was negative for Z...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5297802</comments>
            <pubDate>Tue, 04 Oct 2011 05:51:09 +0100</pubDate>
            <guid isPermaLink="false">5297802</guid>        </item>
        <item>
            <title>Nocardia elegans infection involving purulent arthritis in humans</title>
            <link>http://www.medworm.com/index.php?rid=5297803&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy21r650635g77034%2F</link>
            <description>We describe the first case of N. elegans infection associated with purulent arthritis in humans. The patient was a 66-year-old woman without underlying disease. She
 had swelling in her left ankle that was increasing in size, but it did not cause the patient substantial pain. Punctual discharge
 was collected for Gram staining and Kinyoun’s acid-fast staining. The results of microscopic findings were suggestive of the
 genus Nocardia. The 16S rRNA sequence of the isolate was completely identical (100%) with that of N. elegans, indicating that the isolate was N. elegans. All the previously reported 4 cases of N. elegans infection in humans were associated with respiratory infections; we present the first case of the infection involving purulent
 arthritis.
 
 
	Content Type Journal Articl...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5297803</comments>
            <pubDate>Tue, 04 Oct 2011 05:51:08 +0100</pubDate>
            <guid isPermaLink="false">5297803</guid>        </item>
        <item>
            <title>Bactericidal activity of topical antiseptics and their gargles against Bordetella pertussis</title>
            <link>http://www.medworm.com/index.php?rid=5297804&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff93733667u3vhx00%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;
 Bordetella pertussis is the etiological agent of whooping cough, a common cause of respiratory illness in both children and adults. In the present
 study, we investigated the bactericidal activity of four antiseptics—povidone–iodine (PVP-I), benzethonium chloride (BEC),
 chlorhexidine gluconate (CHG) and benzalkonium chloride (BAC)—against B. pertussis ATCC9797 and clinical isolates. Among the topical antiseptics, PVP-I, BEC, and BAC, PVP-I and BAC in particular, showed high
 bactericidal activity, whereas CHG had low activity. PVP-I gargle also showed high bactericidal activity, similar to topical
 PVP-I. However, BEC gargle had low bactericidal activity. Our results indicate that topical PVP-I and BAC, and PVP-I gargle
 would be useful as effective antiseptics...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5297804</comments>
            <pubDate>Tue, 04 Oct 2011 05:51:07 +0100</pubDate>
            <guid isPermaLink="false">5297804</guid>        </item>
        <item>
            <title>Assessing recovery of renal function after tenofovir disoproxil fumarate discontinuation</title>
            <link>http://www.medworm.com/index.php?rid=5297805&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn3024p0084204lj2%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Impaired renal function caused by tenofovir disoproxil fumarate (TDF) is considered reversible by discontinuing TDF administration,
 but there are occasional cases of incomplete recovery. We investigated the recovery of renal function after the discontinuation
 of TDF. Subjects comprised patients who had been started on TDF but in whom it was later discontinued because of impaired
 renal function. We investigated renal function until 96&amp;nbsp;weeks after the discontinuation of TDF, and the duration of TDF administration,
 up to May 2010. TDF was discontinued because of impaired renal function in 21 of 766 patients (2.7%). Following discontinuation,
 a significant recovery was seen in eGFR (p&amp;nbsp;=&amp;nbsp;0.003). The median duration of administration was 28&amp;nbsp;days (6–...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5297805</comments>
            <pubDate>Tue, 04 Oct 2011 05:51:06 +0100</pubDate>
            <guid isPermaLink="false">5297805</guid>        </item>
        <item>
            <title>Association between antimicrobial consumption and clinical isolates of methicillin-resistant Staphylococcus aureus: a 14-year study</title>
            <link>http://www.medworm.com/index.php?rid=5274982&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa04857x426441377%2F</link>
            <description>The objective of this study was to determine the relationship between clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) and antimicrobial consumption in hospitalized patients over a 14-year period. The study was retrospectively conducted
 between January 1995 and December 2008 at Juntendo University Hospital, Tokyo, Japan, a 1,020-bed tertiary-care teaching hospital.
 The incidence of MRSA isolates was examined using clinical specimens presented to the microbiology laboratory in the hospital.
 Antimicrobial consumption through intravenous injection was calculated in terms of the number of defined daily doses per 100
 bed-days. The correlation between the incidence of MRSA isolates and antimicrobial consumption was determined employing a
 multiple stepwise regression a...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5274982</comments>
            <pubDate>Tue, 27 Sep 2011 05:51:44 +0100</pubDate>
            <guid isPermaLink="false">5274982</guid>        </item>
        <item>
            <title>The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease</title>
            <link>http://www.medworm.com/index.php?rid=5227393&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn410280727000552%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Despite recent advances in chemotherapy, the treatment of pulmonary Mycobacterium avium complex (MAC) disease remains unsatisfactory. Judging from its MIC, fluoroquinolones including gatifloxacin (GFLX) are expected
 to demonstrate efficacy against MAC disease. However, there have been few clinical studies using fluoroquinolones. Therefore,
 a prospective study to evaluate the clinical efficacy and safety of a fluoroquinolone-containing regimen for the treatment
 of pulmonary MAC disease was conducted. In this trial, patients with pulmonary MAC disease received protocol-guided combined
 chemotherapy with rifampin (RFP) and ethambutol (EB) plus either GFLX or clarithromycin (CAM). Adult patients who fulfilled
 the criteria of the ATS definition of pulmonary MAC disease w...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5227393</comments>
            <pubDate>Fri, 16 Sep 2011 16:43:38 +0100</pubDate>
            <guid isPermaLink="false">5227393</guid>        </item>
        <item>
            <title>Fanconi syndrome-like tubular acidosis associated with a tenofovir-containing antiretroviral regimen in a human immunodeficiency virus-1-infected Asian woman</title>
            <link>http://www.medworm.com/index.php?rid=5227394&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj8511781j6j676wq%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A 49-year-old, human immunodeficiency virus-1-infected Asian woman developed Fanconi syndrome-like tubular acidosis while
 taking tenofovir disoproxil fumarate (TDF)/emtricitabine plus lopinavir/ritonavir for 9&amp;nbsp;months. All of her symptoms and abnormalities
 in laboratory tests resolved completely after switching TDF/emtricitabine to zidovudine and lamivudine. We consider that TDF
 caused symptomatic tubular acidosis in the present case, one of the few that has been reported in Japan to date.
 
 
	Content Type Journal ArticleCategory Case ReportPages 1-3DOI 10.1007/s10156-011-0305-3Authors
		Yoshihiko Kiyasu, Department of Infectious Diseases, Tsukuba University Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki 305-8576, JapanHiroshi Koganemaru, Department of Infectious Dis...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5227394</comments>
            <pubDate>Wed, 14 Sep 2011 16:08:53 +0100</pubDate>
            <guid isPermaLink="false">5227394</guid>        </item>
        <item>
            <title>Acute motor-sensory axonal Guillain–Barré syndrome with unilateral facial nerve paralysis after rotavirus gastroenteritis in a 2-year-old boy</title>
            <link>http://www.medworm.com/index.php?rid=5227395&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F43v23470r4h36396%2F</link>
            <description>We present a rare case of 2-year-old
 boy with acute motor and sensory polyneuropathy and left-sided facial nerve paralysis after rotavirus infection. He received
 immunoglobulin i.v. with subsequent satisfactory recovery.
 
 
	Content Type Journal ArticleCategory Case ReportPages 1-5DOI 10.1007/s10156-011-0300-8Authors
		Noriki Kamihiro, Department of Pediatrics, Yamada Red Cross Hospital, 810 Takabuku, Misono-cho, Ise, Mie 516-0805, JapanMasamune Higashigawa, Department of Pediatrics, Yamada Red Cross Hospital, 810 Takabuku, Misono-cho, Ise, Mie 516-0805, JapanTomohiro Yamamoto, Department of Pediatrics, Yamada Red Cross Hospital, 810 Takabuku, Misono-cho, Ise, Mie 516-0805, JapanAyako Yoshino, Department of Pediatrics, Yamada Red Cross Hospital, 810 Takabuku, Misono-cho, Ise, Mie 516-08...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5227395</comments>
            <pubDate>Tue, 13 Sep 2011 15:45:07 +0100</pubDate>
            <guid isPermaLink="false">5227395</guid>        </item>
        <item>
            <title>Bacterial pericarditis caused by infected trichilemmal cyst</title>
            <link>http://www.medworm.com/index.php?rid=5227396&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk3576512040kx6u7%2F</link>
            <description>We present a rare case of Staphylococcus pericarditis caused by an infected trichilemmal cyst present on patient’s scalp. Our case emphasizes that all cases of bacterial
 pericarditis should be thoroughly investigated for a source of infection. Constrictive changes can be seen in the pericardium
 postinfection, as in our patient, and should be treated aggressively. To our knowledge, a case of an infected cyst causing
 bacterial pericarditis has never been reported previously in the literature.
 
 
	Content Type Journal ArticleCategory Case ReportPages 1-4DOI 10.1007/s10156-011-0304-4Authors
		Ankur Lodha, Division of Cardiology, Maimonides Medical Center, Brooklyn, NY, USAEvbu Enakpene, Department of Medicine, Maimonides Medical Center, 4802 10th Avenue, Brooklyn, NY 11219, USAMehandi Ha...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5227396</comments>
            <pubDate>Tue, 13 Sep 2011 15:45:06 +0100</pubDate>
            <guid isPermaLink="false">5227396</guid>        </item>
        <item>
            <title>Acute generalized exanthematous pustulosis after ceftriaxone use resembling sepsis</title>
            <link>http://www.medworm.com/index.php?rid=5227397&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg5155664883l5622%2F</link>
            <description>We report a case of ceftriaxone-induced acute generalized exanthematous pustulosis that presented with the appearance of sepsis.
 After discontinuation of ceftriaxone, the findings were improved.
 
 
	Content Type Journal ArticleCategory Case ReportPages 1-3DOI 10.1007/s10156-011-0297-zAuthors
		Abdurrahman Kaya, Department of Infectious Disease, Medical School of Cerrahpasa, Istanbul University, Istanbul, TurkeySibel Yıldız, Department of Infectious Disease, Medical School of Cerrahpasa, Istanbul University, Istanbul, Turkeyİlker İnanc Balkan, Department of Infectious Disease, Medical School of Cerrahpasa, Istanbul University, Istanbul, TurkeyHayyam Eyvazov, Department of Internal Medicine, Medical School of Cerrahpasa, Istanbul University, Istanbul, TurkeyIsıl Bavunoglu, Department ...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5227397</comments>
            <pubDate>Mon, 12 Sep 2011 15:52:58 +0100</pubDate>
            <guid isPermaLink="false">5227397</guid>        </item>
        <item>
            <title>Preventing surgical-site infections after colorectal surgery</title>
            <link>http://www.medworm.com/index.php?rid=5210265&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Flp326704158t1p37%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Surgical-site infection (SSI) is a major contributor to patient mortality rates and health care costs. Due to the high risk
 of bacterial contamination, colorectal surgery is associated with a particularly high risk of postoperative infection. The
 surveillance reported here was conducted at Aichi Medical University Hospital on 304 patients who underwent elective colorectal
 resection—total or partial—from June 2006 to May 2009. To determine risk factors for SSI, multivariate analysis was used.
 Forty-six (15.1%) patients were diagnosed with SSI. Patients who received cefotiam for prophylaxis showed the highest incidence
 of SSI (26.6%), and patients who were administered flomoxef showed the lowest incidence (8.1%). Patients who developed SSI
 were more likely to in...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5210265</comments>
            <pubDate>Fri, 09 Sep 2011 05:45:15 +0100</pubDate>
            <guid isPermaLink="false">5210265</guid>        </item>
        <item>
            <title>Mechanism of drug interaction between a Kampo medicine, byakkokaninjinto, and tetracycline in rats</title>
            <link>http://www.medworm.com/index.php?rid=5210266&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl375277x7118t50p%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We have previously reported that concomitant oral administration of the Kampo medicine, byakkokaninjinto (TJ-34), in extract
 granules, reduced the plasma concentrations of tetracycline (TC) and ciprofloxacin in humans, which might be the result of
 forming a chelate with Ca2+. In the present study, we investigated the effect of a chelating agent, ethylenediaminetetraacetic acid (EDTA), on the plasma
 concentration–time profiles of TC after coadministration of TJ-34 dried extract and TC in rats to clarify whether metal ions
 contained in the TJ-34 dried extract contribute to this interaction. TJ-34 dried extract significantly reduced the plasma
 concentration of TC. The values of maximum concentration (C
 max), area under the plasma concentration–time curve and perc...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5210266</comments>
            <pubDate>Thu, 08 Sep 2011 05:56:46 +0100</pubDate>
            <guid isPermaLink="false">5210266</guid>        </item>
        <item>
            <title>A 7-year-old girl with subcutaneous emphysema, pneumomediastinum, pneumothorax, and pneumoretroperitoneum caused by Mycoplasma pneumoniae pneumonia</title>
            <link>http://www.medworm.com/index.php?rid=5210267&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3x031pr555257727%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A 7-year-old girl presented with subcutaneous emphysema, pneumomediastinum (PM), pneumoretroperitoneum, and pneumothorax caused
 by Mycoplasma pneumoniae (MP). The patient had been treated with clarithromycin for pneumonia at another hospital; however, her condition deteriorated
 and complications developed. Soon after admission to our hospital, we started the patient on minocycline and prednisolone,
 and the complications improved promptly. Laboratory data showed serum ferritin and urinary beta-2-microglobulin levels were
 greatly elevated. We therefore speculated that the patient might have underlying hypercytokinemia. Prednisolone is an effective
 treatment for hypercytokinemia. We therefore recommend prednisolone treatment for cases of severe M. pneumoniae pneumonia...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5210267</comments>
            <pubDate>Thu, 08 Sep 2011 05:56:42 +0100</pubDate>
            <guid isPermaLink="false">5210267</guid>        </item>
        <item>
            <title>Reduction in the incidence of MRSA with use of alcohol-based hand rub solutions and gloves</title>
            <link>http://www.medworm.com/index.php?rid=5210269&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu8602pr5w3384517%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Methicillin-resistant Staphylococcus aureus (MRSA) is highly contagious. It is spread by direct contact with MRSA-infected people or objects. Healthcare workers’ hands
 are the most common vehicle for the transmission of healthcare-associated pathogens from patient to patient and within the
 healthcare environment. The present study aimed to investigate the correlation between the incidence of MRSA among Staphylococcus aureus recovered from clinical culture and the use of alcohol-based hand rub solutions or gloves and antimicrobial use density (AUD).
 All data were examined every 6&amp;nbsp;months between January 2005 and June 2008. The increasing use of alcohol-based hand rub solutions
 was correlated with a decreasing incidence of recovery of MRSA from clinical cultures...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5210269</comments>
            <pubDate>Mon, 05 Sep 2011 16:14:42 +0100</pubDate>
            <guid isPermaLink="false">5210269</guid>        </item>
        <item>
            <title>A report from the committee on microbroth dilution antimicrobial susceptibility testing</title>
            <link>http://www.medworm.com/index.php?rid=5210268&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F47464744r04n7m30%2F</link>
            <description>Content Type Journal ArticleCategory Committee ReportPages 1-10DOI 10.1007/s10156-011-0277-3Authors
		Keizo Yamaguchi, Department of Microbiology and Infectious Diseases, School of Medicine, Faculty of Medicine, Toho University, Tokyo, JapanYoichi Hirakata, Department of Clinical Microbiology and Management and Analysis of Infectious Diseases, Tohoku University Graduate School of Medicine, Sendai, JapanIntetsu Kobayashi, Department of Infection Control and Prevention, School of Nursing, Faculty of Medicine, Toho University, Tokyo, JapanMasanari Ikedo, Biochemical Research Laboratory, Research and Department Headquaters, Eiken Chemical Co. Ltd, Tochigi, JapanAkira Ohno, Department of Microbiology and Infectious Diseases, School of Medicine, Faculty of Medicine, Toho University, Tokyo, Jap...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5210268</comments>
            <pubDate>Mon, 05 Sep 2011 16:14:42 +0100</pubDate>
            <guid isPermaLink="false">5210268</guid>        </item>
        <item>
            <title>A case of meningitis due to Neisseria subflava after ventriculostomy</title>
            <link>http://www.medworm.com/index.php?rid=5210270&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F32842672q6k33177%2F</link>
            <description>In this report, we describe a case of SSI caused by Neisseria subflava a month after ventriculostomy placement for acute hydrocephalus. A 53-year old man was referred to our hospital, and was
 diagnosed with a thalamic hemorrhage with ventricular rupture. Bilateral ventriculostomies were performed on the day of presentation.
 After intensive care for the acute stage, an SSI at the left ventriculostomy site was recognized on the 39th hospital day.
 The installed reservoir and ventricular tube was removed on the 40th hospital day. The CSF cell count was 2064/3, and N. subflava was recovered from the CSF culture. N. subflava is a common inhabitant found in the human upper respiratory tract, and is reported to be a rare cause of meningitis. There
 is one case report of meningitis caused by N. ...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5210270</comments>
            <pubDate>Mon, 05 Sep 2011 16:14:41 +0100</pubDate>
            <guid isPermaLink="false">5210270</guid>        </item>
        <item>
            <title>High and continuous exposure of laninamivir, an anti-influenza drug, may work suppressively to generate low-susceptibility mutants in animals</title>
            <link>http://www.medworm.com/index.php?rid=5185039&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F510pm16565586u62%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Laninamivir octanoate (Inavir®; Daiichi Sankyo, Tokyo, Japan) is an anti-influenza drug that provides complete treatment by a single inhalation. It works
 as a long-acting neuraminidase (NA) inhibitor by means of high and continuous exposure of laninamivir, its active metabolite,
 in the lungs of mice after intranasal administration. Even after 6&amp;nbsp;days after intranasal administration of 236&amp;nbsp;μg/kg laninamivir
 octanoate, the concentration of laninamivir in the lungs was maintained more than 2–3 orders higher than 50% inhibitory concentrations
 of laninamivir to N1 NAs, about 2 orders higher than N2 NA of seasonal influenza A viruses, and more than about 50 times higher
 than influenza B virus NA. From A/H1N1 influenza virus-infected and laninamivir octanoate...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5185039</comments>
            <pubDate>Wed, 31 Aug 2011 15:56:06 +0100</pubDate>
            <guid isPermaLink="false">5185039</guid>        </item>
        <item>
            <title>Comparison of QuantiFERON-TB Gold and the tuberculin skin test for the detection of previous tuberculosis infection evaluated by chest CT findings in Japanese rheumatoid arthritis patients</title>
            <link>http://www.medworm.com/index.php?rid=5185040&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4738458614157277%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-2DOI 10.1007/s10156-011-0293-3Authors
		Tsukasa Ohnishi, Respiratory and Allergy Division, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-0064 Japan
	

	
		Journal Journal of Infection and ChemotherapyOnline ISSN 1437-7780Print ISSN 1341-321X (Source: Journal of Infection and Chemotherapy)</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5185040</comments>
            <pubDate>Wed, 31 Aug 2011 15:56:03 +0100</pubDate>
            <guid isPermaLink="false">5185040</guid>        </item>
        <item>
            <title>Mediterranean spotted fever and encephalitis: a case report and review of the literature</title>
            <link>http://www.medworm.com/index.php?rid=5185041&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F76l463k51863x456%2F</link>
            <description>We describe the case of a man
 with fever, maculopapular rash, a black spot, and hemisensory loss including the face on the left side of the body with brain
 lesions in the imaging studies.
 
 
	Content Type Journal ArticleCategory Case ReportPages 1-4DOI 10.1007/s10156-011-0295-1Authors
		Vitor Duque, Serviço de Doenças Infecciosas, Hospitais da Universidade de Coimbra, EPE, Avenida Bissaya Barreto e Praceta Prof. Mota Pinto, 3000-075 Coimbra, PortugalConceição Ventura, Serviço de Doenças Infecciosas, Hospitais da Universidade de Coimbra, EPE, Avenida Bissaya Barreto e Praceta Prof. Mota Pinto, 3000-075 Coimbra, PortugalDiana Seixas, Serviço de Doenças Infecciosas, Hospitais da Universidade de Coimbra, EPE, Avenida Bissaya Barreto e Praceta Prof. Mota Pinto, 3000-075 Coimbra, Port...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5185041</comments>
            <pubDate>Tue, 30 Aug 2011 15:56:32 +0100</pubDate>
            <guid isPermaLink="false">5185041</guid>        </item>
        <item>
            <title>Tuberculosis of breast: unusual manifestation of tuberculosis</title>
            <link>http://www.medworm.com/index.php?rid=5185042&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn30985k26254h438%2F</link>
            <description>We report two cases of primary tuberculosis of breast with different manifestations.
 One case presented as tuberculous mastitis and the other presented with a lump masquerading as breast carcinoma. The diagnosis
 in both cases was based on demonstration of acid-fast bacilli on histopathological examination. Resolution was complete with
 antitubercular therapy, and major surgical intervention was not necessary.
 
 
	Content Type Journal ArticleCategory Case ReportPages 1-3DOI 10.1007/s10156-011-0296-0Authors
		Uday Yanamandra, Department of Internal Medicine, Armed Forces Medical College, Pune, 411040 Maharashtra, IndiaNishant Pathak, Department of Internal Medicine, Armed Forces Medical College, Pune, 411040 Maharashtra, IndiaNardeep Naithani, Department of Internal Medicine, Armed Forces...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5185042</comments>
            <pubDate>Tue, 30 Aug 2011 15:56:31 +0100</pubDate>
            <guid isPermaLink="false">5185042</guid>        </item>
        <item>
            <title>Erratum to: Evaluation of resistance mechanisms and serotype and genotype distributions of macrolide-resistant strains in clinical isolates of Streptococcus pneumoniae in Aydın, Turkey</title>
            <link>http://www.medworm.com/index.php?rid=5170988&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F80r604673r415631%2F</link>
            <description>Content Type Journal ArticleCategory ErratumPages 1-1DOI 10.1007/s10156-011-0290-6Authors
		Murat Telli, Medical Microbiology Department, Medical Faculty, Adnan Menderes University, Aydın, 09010 TurkeyMete Eyigör, Medical Microbiology Department, Medical Faculty, Adnan Menderes University, Aydın, 09010 TurkeyBerna Gültekin, Medical Microbiology Department, Medical Faculty, Adnan Menderes University, Aydın, 09010 TurkeyNeriman Aydın, Medical Microbiology Department, Medical Faculty, Adnan Menderes University, Aydın, 09010 Turkey
	

	
		Journal Journal of Infection and ChemotherapyOnline ISSN 1437-7780Print ISSN 1341-321X (Source: Journal of Infection and Chemotherapy)</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5170988</comments>
            <pubDate>Fri, 26 Aug 2011 16:17:06 +0100</pubDate>
            <guid isPermaLink="false">5170988</guid>        </item>
        <item>
            <title>Inhibitory effects of lactoferrin on biofilm formation in clinical isolates of Pseudomonas aeruginosa</title>
            <link>http://www.medworm.com/index.php?rid=5163621&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm6w06v4815423742%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Lactoferrin, a multifunctional protein with antimicrobial activity, is a component of the innate immune system. It may possibly
 prevent clinical isolates of Pseudomonas aeruginosa from developing biofilm, but this hypothesis is yet to be widely accepted. We evaluated the in vitro effects of lactoferrin
 on biofilm formation by various clinical isolates of P. aeruginosa using a modified method of the microtiter plate biofilm assay. Lactoferrin significantly inhibited biofilm formation in these
 isolates. The effect was the most marked at 2&amp;nbsp;mg/ml, which suggested that an optimal concentration of lactoferrin might exist.
 Lactoferrin inhibited biofilm formation in eight of nine clinical isolates after 1&amp;nbsp;day of incubation; however, the inhibitory
 effects were ma...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5163621</comments>
            <pubDate>Wed, 24 Aug 2011 16:04:28 +0100</pubDate>
            <guid isPermaLink="false">5163621</guid>        </item>
        <item>
            <title>Risk factors of septic shock in bacteremic acute pyelonephritis patients admitted to an ER</title>
            <link>http://www.medworm.com/index.php?rid=5163622&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft3331n6028173l5m%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Our objective was to identify factors associated with septic shock in patients with bacteremic acute pyelonephritis who were
 admitted to our emergency department (ER). We performed a retrospective cohort study of 208 adult cases compiled between January
 2000 and December 2010. The mean age of the 208 predominantly female (81.3%) adult cases enrolled during the study period
 was 65.9&amp;nbsp;±&amp;nbsp;15.2&amp;nbsp;years. The overall mortality rate was 6.7% (14/208), but the mortality rate of 54 patients (26%, 54/208) who
 initially presented with shock was 25.9% (14/54). Multiple logistic regression analyses revealed that the independent risk
 factors for the occurrence of septic shock were the presence of a urinary tract obstruction (OR 4.391, 95% CI 1.782–10.821,
 P&amp;nbsp;=...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5163622</comments>
            <pubDate>Mon, 22 Aug 2011 16:00:00 +0100</pubDate>
            <guid isPermaLink="false">5163622</guid>        </item>
        <item>
            <title>Widespread use of neuraminidase inhibitors in Japan</title>
            <link>http://www.medworm.com/index.php?rid=5163623&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr606737428435368%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Almost all patients with an influenza-like illness in Japan are now tested with rapid diagnostic tests, and when positive,
 they are treated with a neuraminidase inhibitor (NAI). Japan may have had the lowest case fatality rate for symptomatic illness
 (&amp;lt;0.001%, 198/20.7 million) in the H1N1/09 pandemic because of the universal implementation of early treatment with NAI. A
 study of 1,000 children hospitalized because of a H1N1/09 infection revealed that NAIs, primarily oseltamivir, had been used
 to treat 984 (98.4%) of the 1,000 patients. In 88.9% of the patients, treatment with NAIs was initiated within 48&amp;nbsp;h after
 the onset of illness. In addition to oseltamivir and zanamivir, the newly approved inhalant drug, laninamivir, and the newly
 approved intravenous...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5163623</comments>
            <pubDate>Thu, 18 Aug 2011 06:03:25 +0100</pubDate>
            <guid isPermaLink="false">5163623</guid>        </item>
        <item>
            <title>Efficacy and safety of moxifloxacin for community-acquired bacterial pneumonia based on pharmacokinetic analysis</title>
            <link>http://www.medworm.com/index.php?rid=5163624&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff0897r0543611185%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Moxifloxacin is a respiratory quinolone that is expected to be useful for treating community-acquired bacterial pneumonia,
 but few clinical studies and not a detailed evaluation of its pharmacokinetics have been conducted in Japan in patients with
 pneumonia. We assessed the efficacy and safety of moxifloxacin in 18 patients with community-acquired bacterial pneumonia
 using pharmacokinetic–pharmacodynamic analysis. There was significant improvement in body temperature, white blood cell count,
 C-reactive protein, and chest X-ray score on day 3 of moxifloxacin treatment, which persisted until the completion of treatment
 (all p&amp;nbsp;&amp;lt;&amp;nbsp;0.05). Nine strains, including Streptococcus pneumoniae, Moraxella catarrhalis, Haemophilus influenzae, and Enterobacter cloac...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5163624</comments>
            <pubDate>Wed, 17 Aug 2011 05:54:00 +0100</pubDate>
            <guid isPermaLink="false">5163624</guid>        </item>
        <item>
            <title>Epidemiological survey of rifampicin resistance in clinic isolates of Brucella melitensis obtained from all regions of Turkey</title>
            <link>http://www.medworm.com/index.php?rid=5120628&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9407086757q2n4q7%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The aim of the present study was to assess the antimicrobial susceptibility of Brucella melitensis isolates to rifampicin (RIF) depending on time and regional differences. A total of 94 human Brucella isolates collected in an 8-year period from the beginning of 2002 to the end of 2009 throughout Turkey were investigated.
 The isolates were identified at species and biovar levels by conventional methods, and minimum inhibitory concentrations (MIC)
 of RIF was determined by using the E test method. All isolates were identified as B. melitensis (93 isolates, biovar 3; 1, biovar 1), and MIC50 and MIC90 values of RIF were 1 and 1.5&amp;nbsp;μg/ml, respectively (MIC range, 0.25–1.5&amp;nbsp;μg/ml). All isolates were sensitive to RIF except 2
 isolates, which had intermediate susc...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5120628</comments>
            <pubDate>Tue, 09 Aug 2011 05:45:14 +0100</pubDate>
            <guid isPermaLink="false">5120628</guid>        </item>
        <item>
            <title>Preventive effect of selenium on chronic bacterial prostatitis</title>
            <link>http://www.medworm.com/index.php?rid=5110663&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh6562r72j88h3804%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The antibiotic treatment rate of chronic bacterial prostatitis (CBP) is low, and long-term administration can result in adverse
 events and bacterial resistance. For these reasons, a new preventive modality, which can replace traditional antibiotic therapy,
 is required. To evaluate the preventive effect of selenium on CBP, the pre-treatments were divided into four groups, administered
 for 4&amp;nbsp;weeks, as follows: (1) control, (2) ciprofloxacin, (3) selenium, and (4) ciprofloxacin and selenium. Then, drip infusion
 of a bacterial suspension (Escherichia coli Z17, O2:K1; H–) into the prostatic urethra of Wistar rats was conducted to induce CBP. In 4&amp;nbsp;weeks, the results of microbiological
 culture of prostate and urine samples as well as histological findings of t...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5110663</comments>
            <pubDate>Thu, 04 Aug 2011 15:23:09 +0100</pubDate>
            <guid isPermaLink="false">5110663</guid>        </item>
        <item>
            <title>Investigation of the clinical breakpoints of piperacillin–tazobactam against infections caused by Pseudomonas aeruginosa</title>
            <link>http://www.medworm.com/index.php?rid=5110664&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq6lm702074024642%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The pharmacokinetics–pharmacodynamics (PK–PD) breakpoint of piperacillin/tazobactam (PIPC/TAZ) for hospital-acquired pneumonia
 (HAP) and Pseudomonas aeruginosa-induced bacteremia is controversial, since the susceptibility of P. aeruginosa to PIPC/TAZ is known to be lower than that set by the Clinical Laboratory Standards Institute (CLSI), ≤64&amp;nbsp;mg/L. The association
 between MIC levels and bacterial eradication after various PIPC/TAZ treatments was investigated. In all, 61 and 17 Japanese
 patients from the microbiology laboratory database with HAP and P. aeruginosa-induced bacteremia, respectively, who were treated with PIPC/TAZ (4.5&amp;nbsp;g, b.i.d., t.i.d., or q.i.d.) between 2008 and 2009
 were retrospectively analyzed. Pertinent clinical data were retrieved...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5110664</comments>
            <pubDate>Thu, 04 Aug 2011 15:23:07 +0100</pubDate>
            <guid isPermaLink="false">5110664</guid>        </item>
        <item>
            <title>Immunogenicity of intradermal vaccination of Japanese rabies vaccine for preexposure immunization following WHO recommendation</title>
            <link>http://www.medworm.com/index.php?rid=5098787&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm515pm0t87305255%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In the present study, we evaluated the immunogenicity of intradermal vaccination of Japanese purified chick embryo cell rabies
 vaccine (PCEC-K) for preexposure immunization (PEI). A total of 39 healthy subjects were administered a single 0.1-ml dose
 of PCEC-K intradermally at the antebrachial region on days 0, 7, and 28. To assess immunogenicity, rabies neutralizing antibody
 (NA) titers were measured on days 7, 28, and 42 post vaccination. By day 42, all subjects developed NA titers ≥0.5&amp;nbsp;IU/ml (geometric
 mean titer, 2.7&amp;nbsp;IU/ml), a level that is considered protective. The vaccine was well tolerated; vaccinated subjects displayed
 minimal redness and pruritus. Although a 1.0-ml dose of PCEC-K administered subcutaneously is considered the standard method,
 t...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5098787</comments>
            <pubDate>Tue, 02 Aug 2011 06:18:13 +0100</pubDate>
            <guid isPermaLink="false">5098787</guid>        </item>
        <item>
            <title>Analysis of cases of severe respiratory failure in children with influenza (H1N1) 2009 infection in Japan</title>
            <link>http://www.medworm.com/index.php?rid=5098788&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv6320404r9226426%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Influenza (H1N1) 2009 occurred in Mexico in April 2009, quickly spread around the world, and was found in Japan in May. Many
 pediatric patients experienced encephalopathy, acute respiratory distress syndrome, and severe pneumonia. The subjects of
 this study were 31 pediatric patients who needed mechanical ventilation due to respiratory failure caused by influenza (H1N1)
 2009 as reported to the Emergency Medical Information Center of the Japan Pediatric Society in Kanagawa Prefecture in Japan
 from August 1 to December 31, 2009. The diagnosis of influenza (H1N1) 2009 infection was based on positive results of a real-time
 polymerase chain reaction. No patient was diagnosed as having a bacterial infection. The average arterial PaO2/FiO2 ratio was significantly decrease...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5098788</comments>
            <pubDate>Tue, 02 Aug 2011 06:18:12 +0100</pubDate>
            <guid isPermaLink="false">5098788</guid>        </item>
        <item>
            <title>Optimal treatment schedule of meropenem for adult patients with febrile neutropenia based on pharmacokinetic–pharmacodynamic analysis</title>
            <link>http://www.medworm.com/index.php?rid=5064410&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fvg741q184kl776t7%2F</link>
            <description>The objectives of this study were to develop a population pharmacokinetic (PK) model of meropenem, to simulate the percent
 time above minimum inhibitory concentration (%T &amp;gt; MIC) at various MICs, and to estimate effective dosage regimens by calculating
 the target attainment rates against various strains of bacteria. A total of 209 plasma samples (1–3 concentrations per patient)
 were obtained from 98 adult Japanese patients with febrile neutropenia in an open-labeled Phase 3 study. The final population
 PK model was fit to a two-compartment model with zero-order input. Creatinine clearance had a positive significant correlation
 with CL. Gender had a significant effect on Vc; however, this effect was small, and the PK profile in male patients was similar
 to that in female patients. ...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5064410</comments>
            <pubDate>Tue, 19 Jul 2011 23:40:12 +0100</pubDate>
            <guid isPermaLink="false">5064410</guid>        </item>
        <item>
            <title>Identifying risk factors for refractory febrile neutropenia in patients with lung cancer</title>
            <link>http://www.medworm.com/index.php?rid=5064411&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ful47v1607r1634u4%2F</link>
            <description>In this study,
 we tried to identify the risk factors for refractory febrile neutropenia in patients with lung cancer. A total of 59 neutropenic
 fever episodes associated with anti-tumor chemotherapy for lung cancer were retrospectively analyzed. We compared patient
 characteristics according to their initial response to treatment with antibiotics. For 34 of 59 (58%) episodes a response
 to initial antibiotics was obtained whereas 25 of 59 (42%) were refractory to treatment. Multivariate analysis demonstrated
 independent risk factors for refractory febrile neutropenia with lung cancer. These risk factors were the severity of febrile
 neutropenia (odds ratio (OR) 6.11; 95% confidence interval (CI) 1.85–20.14) and C-reactive protein more than 10&amp;nbsp;mg/dl (OR
 4.39; 95% CI 1.22–15.74)...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5064411</comments>
            <pubDate>Tue, 19 Jul 2011 23:40:11 +0100</pubDate>
            <guid isPermaLink="false">5064411</guid>        </item>
        <item>
            <title>Time course of virulence factors produced by group A streptococcus during a food-borne epidemic</title>
            <link>http://www.medworm.com/index.php?rid=5031411&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F43n1387qh7043g6p%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We studied the protein amount and activity of the major virulence factors hemolysin, cysteine protease streptococcal pyrogenic
 exotoxin B (SpeB), and NAD glycohydrolase (NADase), which are produced by Streptococcus pyogenes type T-25, with a food poisoning outbreak. The three virulence factors were analyzed by activity and amount of protein using
 supernatants at 2–30&amp;nbsp;h of culture. All these virulence factors were confirmed by their activity. Streptolysin O (SLO), SpeB,
 and NADase were immunochemically confirmed at protein level by Western blot analysis. Two hemolytic forms (70 and 60&amp;nbsp;kDa)
 of SLO were identified. SpeB was detected as a 44-kDa precursor form and a 30-kDa mature form. NADase was 50&amp;nbsp;kDa. SLO protein
 peaked at 8&amp;nbsp;h of culture, which...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5031411</comments>
            <pubDate>Wed, 13 Jul 2011 06:18:37 +0100</pubDate>
            <guid isPermaLink="false">5031411</guid>        </item>
        <item>
            <title>Erratum to: Clinical efficacy of arbekacin for Gram-negative bacteria</title>
            <link>http://www.medworm.com/index.php?rid=5031412&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx740576776711872%2F</link>
            <description>Content Type Journal ArticlePages 1-2DOI 10.1007/s10156-011-0279-1Authors
		Yukihiro Hamada, Department of Pharmacy, Kitasato East University Hospital, 2-1-1, Asamizodai, Minami-ku, Sagamihara, Kanagawa 252-0380, JapanKazuyoshi Tamura, Department of Pharmacy, Kitasato University Hospital, Kanagawa, JapanIkumi Koyama, Kitasato University School of Pharmaceutical Science, Tokyo, JapanMasakazu Kuroyama, Department of Pharmacy, Kitasato East University Hospital, 2-1-1, Asamizodai, Minami-ku, Sagamihara, Kanagawa 252-0380, JapanKazuo Yago, Department of Pharmacy, Kitasato University Hospital, Kanagawa, JapanKeisuke Sunakawa, Kitasato University of Kitasato Institute for Life Sciences, Tokyo, Japan
	

	
		Journal Journal of Infection and ChemotherapyOnline ISSN 1437-7780Print ISSN 1341-321X (S...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5031412</comments>
            <pubDate>Tue, 12 Jul 2011 06:01:19 +0100</pubDate>
            <guid isPermaLink="false">5031412</guid>        </item>
        <item>
            <title>Erratum to: Evaluation of the safety and efficacy of micafungin in Japanese patients with deep mycosis: a post-marketing survey report</title>
            <link>http://www.medworm.com/index.php?rid=5021830&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk23853659812153x%2F</link>
            <description>Content Type Journal ArticlePages 1-1DOI 10.1007/s10156-011-0278-2Authors
		Tomoko Hanadate, Post-Marketing Medical Research, Astellas Pharma Inc., 3-17-1 Hasune, Itabashi-ku, Tokyo, 174-8612 JapanMasahiro Wakasugi, Post-Marketing Medical Research, Astellas Pharma Inc., 3-17-1 Hasune, Itabashi-ku, Tokyo, 174-8612 JapanKeizo Sogabe, Post-Marketing Medical Research, Astellas Pharma Inc., 3-17-1 Hasune, Itabashi-ku, Tokyo, 174-8612 JapanToshimitsu Kobayashi, Post-Marketing Medical Research, Astellas Pharma Inc., 3-17-1 Hasune, Itabashi-ku, Tokyo, 174-8612 JapanHisanori Horita, Post-Marketing Medical Research, Astellas Pharma Inc., 3-17-1 Hasune, Itabashi-ku, Tokyo, 174-8612 JapanIkuo Kawamura, Post-Marketing Medical Research, Astellas Pharma Inc., 3-17-1 Hasune, Itabashi-ku, Tokyo, 174-8612...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5021830</comments>
            <pubDate>Sat, 09 Jul 2011 06:15:33 +0100</pubDate>
            <guid isPermaLink="false">5021830</guid>        </item>
        <item>
            <title>Effect of the steroid receptor antagonist RU486 (mifepristone) on an IFNγ-induced persistent Chlamydophila pneumoniae infection model in epithelial HEp-2 cells</title>
            <link>http://www.medworm.com/index.php?rid=5021831&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F33j436108177l421%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We have previously demonstrated that the steroid receptor antagonist mifepristone (RU486) causes growth inhibition of Chlamydophila pneumoniae by binding to and subsequently destroying the bacteria during their normal developmental cycle in epithelial HEp-2 cells.
 In the present study, we assessed the efficacy of treatment with RU486 against persistent C. pneumoniae infection in interferon (IFN)γ-treated HEp-2 cells. Assessment of bacterial growth modification, the number of infectious
 progenies, the formation of inclusions, and the expressions of the C. pneumoniae genes 16S rRNA and hsp60 were investigated in cells with or without IFNγ stimulation in the presence of RU486, using an inclusion-forming unit (IFU)
 assay, fluorescence microscopic analysis, and reverse ...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5021831</comments>
            <pubDate>Sat, 09 Jul 2011 06:15:32 +0100</pubDate>
            <guid isPermaLink="false">5021831</guid>        </item>
        <item>
            <title>Synthesis and minimum inhibitory concentrations of SK-03-92 against Staphylococcus aureus and other gram-positive bacteria</title>
            <link>http://www.medworm.com/index.php?rid=5021832&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4476505m743j22kt%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;
 Staphylococcus aureus causes hundreds of thousands of infections and thousands of deaths per year in the United States. The emergence of methicillin-resistant
 S. aureus (MRSA), including community-associated methicillin-resistant S. aureus (CA-MRSA), has added to the problem. As MRSA continue to evolve, they are becoming resistant to more classes of antibiotics.
 In the past 20 years, only three new antibiotics have been approved for human use (linezolid, daptomycin, and tigecycline),
 and resistance to these three drugs has already emerged. New antibiotics are needed, and we have developed a promising drug
 candidate that may be applicable to treating MRSA, among other gram-positive bacterial infections. We have identified a novel
 synthetic drug, coded SK-03-92, th...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5021832</comments>
            <pubDate>Fri, 08 Jul 2011 06:28:49 +0100</pubDate>
            <guid isPermaLink="false">5021832</guid>        </item>
        <item>
            <title>Correlation between HIV disease and lipid metabolism in antiretroviral-naïve HIV-infected patients in Japan</title>
            <link>http://www.medworm.com/index.php?rid=5021833&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp371681418u7l528%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Antiretroviral therapy alters lipid metabolism in HIV-infected patients. However, interpreting the impact of HIV infection
 on lipid metabolism is difficult because of various associated factors, including antiretroviral drugs and demographic characteristics.
 A few studies have associated HIV infection with lipid metabolism in antiretroviral-naïve HIV-infected patients. Because there
 were no data in this regard from Japan, the present study examined the impact of HIV infection, as well as demographic and
 clinical features, on lipid metabolism in antiretroviral-naïve HIV-infected patients in Japan. We performed a cross-sectional
 study to examine the impact of HIV disease, demographic and clinical characteristics on lipid metabolism among 168 HIV-infected
 Japanese ...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5021833</comments>
            <pubDate>Thu, 07 Jul 2011 05:42:52 +0100</pubDate>
            <guid isPermaLink="false">5021833</guid>        </item>
        <item>
            <title>Evaluation of a simultaneous detection kit for the glutamate dehydrogenase antigen and toxin A/B in feces for diagnosis of Clostridium difficile infection</title>
            <link>http://www.medworm.com/index.php?rid=5000117&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fcg067435117l00pj%2F</link>
            <description>In this study, we evaluated a new rapid diagnostic
 kit for simultaneous detection of the glutamate dehydrogenase (GDH) antigen and toxin A/B, C. DIFF QUIK CHEK COMPLETE. A total of 60 stool specimens from 60 patients with antibiotic-associated diarrhea were examined. Using
 C. difficile culture as the reference method, the GDH portion of this kit indicated a sensitivity, specificity, and negative predictive
 value of 100, 93.3, and 100%, respectively. The toxin A/B portion showed a sensitivity and specificity of 78.6 and 96.9%,
 respectively, compared to the culture results of toxin B-positive C. difficile (toxigenic culture). Of the 23 specimens that showed “dual positives” for GDH and toxin A/B, 22 were toxigenic culture positive,
 whereas C. difficile culture was negative in all th...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5000117</comments>
            <pubDate>Fri, 01 Jul 2011 17:42:34 +0100</pubDate>
            <guid isPermaLink="false">5000117</guid>        </item>
        <item>
            <title>Does antimicrobial homogeneity index influence surgical site infection? A 10-year study in lung, breast, and general surgery</title>
            <link>http://www.medworm.com/index.php?rid=4987023&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd70816812277220j%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;To address whether hospital antimicrobial use influences surgical site infection (SSI), we investigated factors including
 antimicrobial homogeneity index (AHI), an indicator of prescription diversity, with a retrospective study during 120&amp;nbsp;months
 for patients undergoing lung, breast, and general surgery (n&amp;nbsp;=&amp;nbsp;4,510). We analyzed the odds ratios of background factors for SSI and the correlation between AHI and drug susceptibility
 in isolates of SSI. A total of 243 cases of SSI (5.4%) occurred. Factors that significantly contributed for SSI were operative
 time [odds ratio (OR), 1.78; 95% confidence interval (CI), 1.33–2.39; P&amp;nbsp;&amp;lt;&amp;nbsp;0.001], American Society of Anesthesiologists’ score (OR, 1.68, 95% CI, 1.23–2.28; P&amp;nbsp;&amp;lt;&amp;nbsp;0.001), en...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4987023</comments>
            <pubDate>Mon, 27 Jun 2011 17:48:28 +0100</pubDate>
            <guid isPermaLink="false">4987023</guid>        </item>
        <item>
            <title>Exploration of optimal teicoplanin dosage based on pharmacokinetic parameters for the treatment of intensive care unit patients infected with methicillin-resistant Staphylococcus aureus</title>
            <link>http://www.medworm.com/index.php?rid=4987024&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fvp634u2534q27194%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Severely ill intensive care unit (ICU) patients are frequently at risk of developing methicillin-resistant Staphylococcus aureus (MRSA) infections. It is generally accepted that a trough level of &amp;gt;10&amp;nbsp;μg/mL teicoplanin (TEC) is appropriate for most such
 infections. The present study was designed to determine how TEC exposure and patient characteristics affect microbiological
 response in the treatment of MRSA infections. All patients studied were admitted to Aichi Medical University Hospital ICU
 between May 2005 and April 2010. Fifty-nine patients were prescribed TEC and 33 of those patients used to treat MRSA infection.
 Outcome was classified as either cure or failure, and logistic regression analysis was performed to determine which covariates,
 including s...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4987024</comments>
            <pubDate>Mon, 27 Jun 2011 17:48:27 +0100</pubDate>
            <guid isPermaLink="false">4987024</guid>        </item>
        <item>
            <title>In vitro activity of azithromycin against Mycoplasma genitalium and its efficacy in the treatment of male Mycoplasma genitalium-positive nongonococcal urethritis</title>
            <link>http://www.medworm.com/index.php?rid=4987025&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc0620n73nx13812q%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Many recent studies have shown that Mycoplasma genitalium is among the pathogens responsible for Chlamydia
 trachomatis-negative nongonococcal urethritis (NGU). A single 1-g dose of azithromycin (AZM) has been recommended for the treatment of
 NGU, including M. genitalium-positive NGU, irrespective of whether it is positive or negative for Chlamydia
 trachomatis. The purpose of this study was to determine the minimal inhibitory concentrations of AZM against Mycoplasma genitalium strains, and to assess its clinical efficacy against Mycoplasma genitalium-positive NGU. Seven Mycoplasma genitalium strains were obtained from the American Type Culture Collection, and susceptibility testing of seven antimicrobial agents
 was performed using a broth microdilution method. Thirty...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4987025</comments>
            <pubDate>Mon, 27 Jun 2011 17:48:26 +0100</pubDate>
            <guid isPermaLink="false">4987025</guid>        </item>
        <item>
            <title>Invasive Streptococcus pneumoniae infections in children in Kamikawa and Soya subprefecture, Hokkaido, Japan, 2000–2010, before the introduction of the 7-valent pneumococcal conjugate vaccine</title>
            <link>http://www.medworm.com/index.php?rid=4971209&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl550x2rm33045532%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We evaluated 103 cases of invasive pneumococcal disease (IPD) encountered in 99 children (two developed the disease twice
 and one, three times) treated in the northern district of Hokkaido (Kamikawa and Soya subprefecture) from April 2000 until
 March 2010, before the introduction of the 7-valent pneumococcal conjugate vaccine. The main diseases were as follows: pneumonia,
 54 cases (52.9%); occult bacteremia, 34 cases (33.3%); meningitis, five cases (4.9%). There were 42 cases during the first
 half of the study period (from April 2000 to March 2005) and 61 during the second half (from April 2005 to March 2010). The
 IPD morbidity rate for the 10-year period was 41.3 per 100,000 population in children &amp;lt;5&amp;nbsp;years and 79.2 per 100,000 population
 in children &amp;lt;2...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4971209</comments>
            <pubDate>Fri, 24 Jun 2011 05:45:39 +0100</pubDate>
            <guid isPermaLink="false">4971209</guid>        </item>
        <item>
            <title>Clinical implications of interleukin-18 levels in pediatric patients with Mycoplasma pneumoniae pneumonia</title>
            <link>http://www.medworm.com/index.php?rid=4947085&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Flx688r2u10166007%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The immunological pathogenesis of Mycoplasma pneumoniae pneumonia is known to involve several cytokines. The serum levels of interleukin-18 (IL-18) were examined using enzyme-linked
 immunosorbent assay in 23 pediatric patients (median age 6&amp;nbsp;years; range 4–13&amp;nbsp;years; 14 girls and 9 boys) with M. pneumoniae pneumonia admitted to our hospital. Serum levels of IL-18 ranged from 22 to 1808&amp;nbsp;pg/ml with a mean of 543&amp;nbsp;pg/ml. We started
 steroid therapy in two cases with IL-18 values greater than 1000&amp;nbsp;pg/ml without being aware of IL-18 levels. Examination of
 associations between IL-18 levels determined by enzyme-linked immunosorbent assay and a routine laboratory test showed that
 levels of lactate dehydrogenase (LDH) and IL-18 were significantly corre...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4947085</comments>
            <pubDate>Fri, 17 Jun 2011 10:51:04 +0100</pubDate>
            <guid isPermaLink="false">4947085</guid>        </item>
        <item>
            <title>Retrospective study on the effect of tight glucose control in postoperative sepsis patients using an artificial pancreas</title>
            <link>http://www.medworm.com/index.php?rid=4947086&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc575041375588xv4%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Tight glucose control (TGC) using a sliding scale based on intermittent blood glucose measurements occasionally can have a
 fatal outcome as a result of insulin-induced hypoglycemia. The present study was undertaken to examine whether the use of
 an artificial pancreas to achieve TGC would be possible in postoperative patients with sepsis. The retrospective study was
 carried out as an exploratory study, focusing on the possibility of precise evaluation of the significance of TGC as a beneficial
 intervention by serological monitoring of various mediators. TGC was accomplished using an artificial pancreas (STG-22; (Nikkiso,
 Tokyo, Japan). The patients were divided into two groups: the TGC group (6 patients with sepsis in whom the target blood glucose
 level set at &amp;lt;...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4947086</comments>
            <pubDate>Fri, 17 Jun 2011 10:51:03 +0100</pubDate>
            <guid isPermaLink="false">4947086</guid>        </item>
        <item>
            <title>Pancytopenia due to pyrimethamine triggered by transplant-associated microangiopathy after allogeneic bone marrow transplantation</title>
            <link>http://www.medworm.com/index.php?rid=4947087&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6067m6115131055m%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Toxoplasmosis is one of the life-threatening infections that can occur after hematopoietic stem cell transplantation (HSCT)
 and also solid organ transplantation. The standard treatment for toxoplasmosis is combination therapy with pyrimethamine and
 sulfadiazine, both of which inhibit folate metabolism. Therefore, therapy with these agents could result in marrow toxicity
 including megaloblastic anemia or pancytopenia, which is reversible or preventable with folate supplementation. Transplant-associated
 microangiopathy (TAM) is another situation where folate is required to compensate for increased erythropoiesis due to hemolysis
 after allogeneic HSCT. Here, we report a case of severe marrow toxicity manifesting as pancytopenia due to low-dose pyrimethamine,
 which wa...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4947087</comments>
            <pubDate>Wed, 15 Jun 2011 05:48:28 +0100</pubDate>
            <guid isPermaLink="false">4947087</guid>        </item>
        <item>
            <title>Mutations to the probe of Cobas TaqMan HIV-1 ver. 1.0 assay causing undetectable viral load in a patient with acute HIV-1 infection</title>
            <link>http://www.medworm.com/index.php?rid=4947088&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd4378x45714l5hwx%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We encountered a human immunodeficiency virus (HIV)-1 in which the viral load was undetectable with the Cobas TaqMan HIV-1
 ver. 1.0 (CTM v.1.0) in a patient with acute HIV-1 infection. The CTM v.1.0 assay showed more than 1,000-fold underestimation
 compared with the subsequent Cobas Amplicor Monitor v.1.5 assay. Because five mismatches to the CTM v.1.0 assay probe in the
 HIV-1 virus in the patient were disclosed by the manufacturer, partial gag regions of the HIV genome were directly sequenced
 from the patient’s plasma viral RNA. The detected single nucleotide point mutations were located near the 5′-end of the Cobas
 Amplicor Monitor probe. Clinicians should be very careful in making interpretations when indeterminate Western blot analysis
 results and a low or...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4947088</comments>
            <pubDate>Tue, 14 Jun 2011 05:55:56 +0100</pubDate>
            <guid isPermaLink="false">4947088</guid>        </item>
        <item>
            <title>Clinical efficacy of arbekacin for Gram-negative bacteria</title>
            <link>http://www.medworm.com/index.php?rid=4938966&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F037767qwj3305x71%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In an analysis of methicillin-resistant Staphylococcus aureus (MRSA) infected patients treated with arbekacin (ABK) only, Gram-negative bacteria (GNB) that were inhibited by low minimal
 inhibitory concentrations (MICs) of amikacin (AMK) or gentamycin (GM) were eradicated by the end of the ABK treatment. On
 the other hand, GNB that were only inhibited by high MICs of AMK or GM persisted until the end of treatment with ABK only.
 Thus, ABK can be expected to be effective even in cases of mixed infection with GNB and MRSA.
 
 
	Content Type Journal ArticlePages 1-4DOI 10.1007/s10156-011-0262-xAuthors
		Yukihiro Hamada, Department of Pharmacy, Kitasato East University Hospital, 2-1-1, Asamizodai, Minami-ku, Sagamihara, Kanagawa 252-0380, JapanKazuyoshi Tamura, Department ...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4938966</comments>
            <pubDate>Sat, 11 Jun 2011 06:29:40 +0100</pubDate>
            <guid isPermaLink="false">4938966</guid>        </item>
        <item>
            <title>Fatal hemorrhagic pneumonia caused by Stenotrophomanas maltophilia in a patient with non-Hodgkin lymphoma</title>
            <link>http://www.medworm.com/index.php?rid=4923968&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq02457g2r7326227%2F</link>
            <description>We report on a 57-year-old woman treated
 with intensive chemotherapy for non-Hodgkin lymphoma who developed severe neutropenia, hemorrhagic pneumonia, and acute respiratory
 failure, which led to her death within 36&amp;nbsp;h of onset of pneumonia. Postmortem examination revealed bilateral extensive intraalveolar
 hemorrhage associated with severe infection by the gram-negative bacterium Stenotrophomonas maltophilia. In vitro susceptibility testing showed resistance to carbapenem, cephalosporines and aminoglycosides, but sensitivity to
 minocycline, ciprofloxacin, levofloxacin, and trimethoprim/sulfamethoxazole (cotrimoxazole). Early diagnosis and adequate
 antibiotic treatment were difficult, as the clinical course was rapid and fulminant, and this bacterium is resistant to multiple
 antibi...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4923968</comments>
            <pubDate>Wed, 08 Jun 2011 15:47:03 +0100</pubDate>
            <guid isPermaLink="false">4923968</guid>        </item>
        <item>
            <title>Classification of acute encephalopathy in respiratory syncytial virus infection</title>
            <link>http://www.medworm.com/index.php?rid=4914886&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb1q47169662rk564%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Infection with respiratory syncytial virus (RSV) is known to be associated with central nervous system symptoms such as convulsions.
 We investigated cytokines, nitrogen oxide (NO)
 x
 , and the viral genome in cerebrospinal fluid (CSF) obtained from children with RSV infection-related convulsions or central
 nervous symptoms and compared the data with type of encephalopathy. Of nine patients enrolled (six boys and three girls; aged
 10 days–3 years), one metabolic error, five excitotoxicity, one cytokine storm, and two hypoxia cases were found. The patients
 presented with unilateral convulsions, generalized convulsions, and convulsions following cardiopulmonary arrest, apnea, and
 nuchal rigidity. In all patients, a rapid check for RSV of nasal fluid was positive. T...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4914886</comments>
            <pubDate>Mon, 06 Jun 2011 14:57:15 +0100</pubDate>
            <guid isPermaLink="false">4914886</guid>        </item>
        <item>
            <title>Efficacy and safety of single-dose 2.0 g azithromycin in the treatment of acute exacerbation of chronic obstructive pulmonary disease</title>
            <link>http://www.medworm.com/index.php?rid=4896412&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp26g473426487776%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;To evaluate the efficacy and safety of single-dose 2.0&amp;nbsp;g azithromycin (ZSR) in the treatment of acute exacerbation of chronic
 obstructive pulmonary disease (AE-COPD), we retrospectively reviewed all patients with AE-COPD who were treated with ZSR.
 In comparison with patients who received intravenous therapy for AE-COPD, the clinical cure rate, length of stay in hospital,
 and medical costs were evaluated. A total of 29 patients thus were eligible for this study. Clinical cure rates of ZSR and
 intravenous therapy for the treatment of AE-COPD were 83.3% (n&amp;nbsp;=&amp;nbsp;12) and 88.2% (n&amp;nbsp;=&amp;nbsp;17), respectively, between the groups (P&amp;nbsp;=&amp;nbsp;1.000). No severe adverse events were found in either group. The ZSR and intravenous groups averaged 9.9 and 12.5&amp;nbs...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4896412</comments>
            <pubDate>Thu, 02 Jun 2011 06:08:18 +0100</pubDate>
            <guid isPermaLink="false">4896412</guid>        </item>
        <item>
            <title>Degradation of interleukin 8 by the serine protease MucD of Pseudomonas aeruginosa</title>
            <link>http://www.medworm.com/index.php?rid=4896413&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0674wn32582l86ml%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We investigated the influence of the type III effector, ExoS, on the host epithelial cell response to Pseudomonas aeruginosa infection, and we found that disruption of the exoS gene caused a significant increase in the amount of interleukin-8 (IL-8) in the culture medium of Caco-2 cells. We show that
 IL-8 was degraded in the culture medium following infection of the cells with the wild-type (PAO1), but not the exoS knock-out (the ΔexoS) strain. Purified ExoS protein itself did not degrade IL-8. We next show that IL-8 degradation by PAO1 was inhibited by the
 addition of serine protease inhibitors. These results strongly suggest that a bacterial serine protease that degrades IL-8
 is expressed and secreted into the culture medium of Caco-2 cells infected with PAO1, and...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4896413</comments>
            <pubDate>Mon, 30 May 2011 17:09:57 +0100</pubDate>
            <guid isPermaLink="false">4896413</guid>        </item>
        <item>
            <title>A retrospective study of health care-associated pneumonia patients at Aichi Medical University hospital</title>
            <link>http://www.medworm.com/index.php?rid=4855029&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh7lwr5170vm5w416%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Health care-associated pneumonia (HCAP) was defined in the American Thoracic Society/Infectious Disease Society of America
 guidelines on hospital-acquired pneumonia in 2005. However, little is known about the occurrence of HCAP in Japan. A retrospective
 review of background characteristics, pathological conditions, causative organisms, initial treatments, and risk factors for
 HCAP was conducted to determine the relationship of HCAP to community-acquired pneumonia and hospital-acquired pneumonia.
 Thirty-five patients who were admitted to our hospital for pneumonia acquired outside our hospital were included and were
 stratified by disease severity according to the Japanese Respiratory Society risk stratification guidelines (A-DROP [age,
 dehydration, respiratory fail...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4855029</comments>
            <pubDate>Thu, 19 May 2011 16:33:35 +0100</pubDate>
            <guid isPermaLink="false">4855029</guid>        </item>
        <item>
            <title>Electron microscopic study of the effects of antimicrobial agents on the cellular architecture of Leptospira</title>
            <link>http://www.medworm.com/index.php?rid=4855030&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F83g855j33k562673%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Morphological changes of Leptospira induced by ampicillin, streptomycin, or ciprofloxacin were studied by transmission electron microscopy after staining with
 uranyl acetate. Irregularities in coiling, loss of hooks, spherical swellings, membrane vesicle formation, disruption of outer
 membrane, exposure and detachment of flagella, penetration of dye, and lysis of cells were observed. These changes appeared
 in a time-dependent manner and appeared to be associated with the sites of action of antimicrobial agents. This is the first
 report delineating the action of aminoglycoside and new quinolone on the morphology of Leptospira cells.
 
 
	Content Type Journal ArticlePages 1-4DOI 10.1007/s10156-011-0258-6Authors
		Antara Chakraborty, Department of Bacteriology, Graduat...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4855030</comments>
            <pubDate>Thu, 19 May 2011 16:33:33 +0100</pubDate>
            <guid isPermaLink="false">4855030</guid>        </item>
        <item>
            <title>Clinical efficacy of carbapenems on hospital-acquired pneumonia in accordance with the Japanese Respiratory Society Guidelines for management of HAP</title>
            <link>http://www.medworm.com/index.php?rid=4832771&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv67058488356401m%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Hospital-acquired pneumonia (HAP) is the second most common cause of hospital-acquired infection and is the leading cause
 of death. In 2002, the Japanese Respiratory Society (JRS) published guidelines for the diagnosis and treatment of HAP (JRS
 GL 2002). In these guidelines, treatment with carbapenems is recommended for all disease types of HAP, excluding cases of
 mild or moderate pneumonia with no risk factors, and cases with early-onset ventilation-acquired pneumonia. To evaluate the
 efficacy of carbapenems on HAP in accordance with JRS GL 2002, we conducted a prospective study of HAP patients treated with
 carbapenems based on JRS GL 2002. The results of this study were also analyzed based on the revised guidelines published in
 June 2008 (JRS GL 2008), and the v...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4832771</comments>
            <pubDate>Mon, 16 May 2011 15:47:21 +0100</pubDate>
            <guid isPermaLink="false">4832771</guid>        </item>
        <item>
            <title>Recent trends in adult-onset septic arthritis of the knee and hip: retrospective analysis of patients treated during the past 50 years</title>
            <link>http://www.medworm.com/index.php?rid=4832770&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F58662130t7877118%2F</link>
            <description>This study was a retrospective analysis of 53 adult patients with septic arthritis (SA) of the knee or hip treated during
 the years from 1955 to 2005 in Tottori University Hospital in Japan. Patients with postoperative infection, infection caused
 by trauma, and periprosthetic infection were excluded. The 50-year period between 1955 and 2005 was divided into five periods:
 there were 5 patients in the first decade, 9 in the second decade, 11 in the third decade, 10 in the fourth decade, and 18
 in the fifth decade. All SA occurred in the knee until the fourth decade. Five cases of septic arthritis in the hip occurred
 in the fifth decade. In contrast to the decrease in direct infections (post intraarticular injection), hematogenous infections
 were observed to increase after 1986. The rat...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4832770</comments>
            <pubDate>Mon, 16 May 2011 15:47:21 +0100</pubDate>
            <guid isPermaLink="false">4832770</guid>        </item>
        <item>
            <title>Direct detection by real-time PCR of ftsI gene mutations affecting MICs of β-lactam agents for Haemophilus influenzae isolates from meningitis</title>
            <link>http://www.medworm.com/index.php?rid=4832772&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Frht24326lu12l47n%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;One resistance mechanism of Haemophilus influenzae to ampicillin involves decreased affinity of penicillin-binding protein (PBP) 3 for β-lactam antibiotics reflecting amino
 acid substitutions in PBP3 encoded by the ftsI gene. Three amino acid substitutions, Ser385Thr, Arg517His, and Asn526Lys, are especially responsible for β-lactam resistance.
 We constructed a new real-time polymerase chain reaction (PCR) to directly detect these substitutions in addition to 16S ribosomal
 RNA (rRNA), cap, and bla
 TEM genes. Our real-time PCR was evaluated using 206 clinical H. influenzae strains isolated from pediatric patients with meningitis. Relative sensitivities and specificities of real-time PCR were
 90.5–100% and 96.3–100% for all resistance classes compared with our ...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4832772</comments>
            <pubDate>Sat, 14 May 2011 15:51:27 +0100</pubDate>
            <guid isPermaLink="false">4832772</guid>        </item>
        <item>
            <title>Nocardia transvalensis pulmonary infection in an immunocompetent patient with radiographic findings consistent with nontuberculous mycobacterial infections</title>
            <link>http://www.medworm.com/index.php?rid=4832773&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F683mw93114326554%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A chest roentgenogram of a 75-year-old immunocompetent woman showed disseminated micronodular densities in bilateral lung
 fields. Subsequent high-resolution computed tomography (CT) confirmed centrilobular micronodular densities associated with
 bronchial wall thickening and bronchiectatic changes. CT imaging also revealed volume loss with bronchiectatic changes in
 both the right middle lobe and the left lingular segment. Cytology specimens were then obtained through bronchial brushing
 and washes. Smears from right B2 and B4 revealed filamentous gram-positive, branched bacteria embedded among many neutrophils.
 Nocardia transvalensis was cultured from the bronchial wash, and no mycobacteria were identified. To our knowledge, this is the first report of
 a Nocardia tr...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4832773</comments>
            <pubDate>Thu, 12 May 2011 16:45:59 +0100</pubDate>
            <guid isPermaLink="false">4832773</guid>        </item>
        <item>
            <title>Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome</title>
            <link>http://www.medworm.com/index.php?rid=4822839&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fex9274g2200r5236%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;CD14 is present in macrophage, monocyte, and granulocyte cells and their cell membranes, and it is said to be responsible
 for intracellular transduction of endotoxin signals. Its soluble fraction is present in blood and is thought to be produced
 in association with infections. It is called the soluble CD14-subtype (sCD14-ST), and in the following text it is referred
 to by its generic name, presepsin. We have previously reported that presepsin is produced in association with infection and
 that it is specifically expressed in sepsis. In the present study we developed a new rapid diagnostic method by using a chemiluminescent
 enzyme immunoassay that allowed making automated measurements in a shorter time. The results of using this method to measure
 presepsin values in...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4822839</comments>
            <pubDate>Wed, 11 May 2011 06:28:12 +0100</pubDate>
            <guid isPermaLink="false">4822839</guid>        </item>
        <item>
            <title>A case of bacteremia caused by Hafnia paralvei</title>
            <link>http://www.medworm.com/index.php?rid=4806944&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3154q753h4t1216u%2F</link>
            <description>We describe a case of an 85-year-old Japanese man hospitalized
 consequent to suspected cholecystitis, in which Hafnia sp. was recovered from the blood culture concomitantly with Enterococcus faecalis. Sequencing of the 16S ribosomal RNA gene sequence and phenotyping with ID 32 E revealed that the recovered Hafnia sp. was considered to be Hafnia alvei genomosp. 2 (ATCC 29927), recently reclassified as Hafnia paralvei. The patient recovered uneventfully with antimicrobial therapies.
 
 
	Content Type Journal ArticlePages 1-3DOI 10.1007/s10156-011-0255-9Authors
		Hanako Osuka, Department of Infectious Diseases, Tsukuba University Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki 305-8576, JapanShigemi Hitomi, Department of Infectious Diseases, Tsukuba University Hospital, 2-1-1 Amakubo, Tsukuba, Iba...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4806944</comments>
            <pubDate>Fri, 06 May 2011 16:22:47 +0100</pubDate>
            <guid isPermaLink="false">4806944</guid>        </item>
        <item>
            <title>Distribution of micafungin in the tissue fluids of patients with invasive fungal infections</title>
            <link>http://www.medworm.com/index.php?rid=4783458&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe85p2r414580203m%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The distribution of micafungin (MCFG) in tissue fluids, such as cerebrospinal fluid (CSF), pleural effusions, ascites, and
 wound tissue fluids, was examined in seven patients with invasive fungal infections. MCFG (100–300&amp;nbsp;mg) was administered once
 daily over a 1-h intravenous infusion. Blood and tissue fluid samples were collected from 1 to 24&amp;nbsp;h after infusion. Although
 two patients had similar MCFG concentrations in their plasma, the concentrations in the CSF differed between these two patients.
 The concentration in the CSF of one patient was much higher than the MIC90 for Candida albicans, Candida glabrata, and Aspergillus fumigatus, whereas the MCFG concentration in the CSF of the other patient was comparable to the MIC90. By contrast, MCFG concentrat...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4783458</comments>
            <pubDate>Mon, 02 May 2011 15:00:28 +0100</pubDate>
            <guid isPermaLink="false">4783458</guid>        </item>
        <item>
            <title>Splenic abscess caused by MRSA developing in an infarcted area: case report and literature review</title>
            <link>http://www.medworm.com/index.php?rid=4783459&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh5472326183t3644%2F</link>
            <description>We report a case of a 41-year-old man with a splenic abscess caused by methicillin-resistant Staphylococcus aureus (MRSA). He had been treated with antimicrobials and corticosteroids for interstitial pneumonia caused by Mycoplasma pneumoniae and hemolytic anemia. He developed catheter-related (MRSA) bacteremia during his stay in the ICU and was treated with teicoplanin
 for 2&amp;nbsp;weeks. After 4 weeks of outpatient follow-up, he was readmitted to the hospital with fever and pain in the left upper
 quadrant. A thoracoabdominal CT scan showed subcapsular collection in areas of splenic infarction that had been detected on
 his first admission. CT-guided percutaneous aspiration resulted in the isolation of MRSA. The patient was treated successfully
 with teicoplanin for 6&amp;nbsp;weeks. Our aim i...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4783459</comments>
            <pubDate>Mon, 02 May 2011 05:43:33 +0100</pubDate>
            <guid isPermaLink="false">4783459</guid>        </item>
        <item>
            <title>Comparison of QuantiFERON-TB Gold and the tuberculin skin test for detecting previous tuberculosis infection evaluated by chest CT findings in Japanese rheumatoid arthritis patients</title>
            <link>http://www.medworm.com/index.php?rid=4783460&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb19q344qm5467q71%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The aim of the study was to compare the usefulness of the QuantiFERON-TB Gold (QFT-2G) with that of the tuberculin skin test
 (TST) for detecting previous infection of tuberculosis (TB) in Japanese rheumatoid arthritis (RA) patients. Before receiving
 biologic therapy, 97 RA patients were divided into two groups based on their chest computed tomography (CT) findings: the
 TB past infection group (n&amp;nbsp;=&amp;nbsp;48), with old inflammatory changes due to prior pulmonary TB; and the non-TB infection group (n&amp;nbsp;=&amp;nbsp;49), without such findings. The QFT-2G was not affected by methotrexate or prednisolone. Indeterminate results with a positive
 control had a low incidence (5.2%). A positive QFT-2G for the TB past infection group at cutoffs of 0.35 and 0.1&amp;nbsp;IU/ml (inter...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4783460</comments>
            <pubDate>Fri, 29 Apr 2011 05:42:22 +0100</pubDate>
            <guid isPermaLink="false">4783460</guid>        </item>
        <item>
            <title>Abbott RealTime PCR assay is useful for evaluating virological response to antiviral treatment for chronic hepatitis C</title>
            <link>http://www.medworm.com/index.php?rid=4783461&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F70217n24085m4663%2F</link>
            <description>This study was done to evaluate the utility of the Abbott RealTime PCR assay (ART) for the monitoring of chronic hepatitis
 C patients. The serum samples of 183 patients infected with hepatitis C virus (HCV) genotype 1b who had completed a 48-week
 period of pegylated interferon (PEG-IFN) alpha-2b plus ribavirin treatment were prospectively analyzed. Serum HCV RNA levels
 were measured both by ART and by the Roche COBAS Amplicor Monitor test, version2.0 (CAM) at baseline and at weeks 4, 12, 24,
 36, and 48 of treatment, and at 24&amp;nbsp;weeks after the end of treatment (EOT). A significant positive correlation of pretreatment
 HCV RNA levels was found between ART and CAM (r&amp;nbsp;=&amp;nbsp;0.595, P&amp;nbsp;&amp;lt;&amp;nbsp;0.0001). Of the 183 patients, 66 (36.0%) achieved a sustained virological response ...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4783461</comments>
            <pubDate>Thu, 28 Apr 2011 17:17:11 +0100</pubDate>
            <guid isPermaLink="false">4783461</guid>        </item>
        <item>
            <title>Efficacy and safety of antifungal prophylaxis with oral itraconazole solution among patients receiving corticosteroids: who should be given prophylaxis?</title>
            <link>http://www.medworm.com/index.php?rid=4768900&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk235u776k5037618%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The incidence of systemic fungal infections has risen, as shown by increases in the numbers of immunosuppressed or immunocompromised
 patients. The consequences of these fungal infections are occasionally serious. However, the efficacy of antifungal prophylaxis
 in patients receiving corticosteroid treatment has not been well investigated, even though they are susceptible to severe
 fungal infections. Therefore, we retrospectively evaluated the prophylactic efficacy of an antifungal agent—oral itraconazole
 solution (ITCZ-OS)—for immunosuppressed patients receiving corticosteroids in a single institution. Of 39 patients, 18 received
 prophylaxis with ITCZ-OS at a dose of 200&amp;nbsp;mg/day, and 21 did not. As a result, no fungal infections developed in the prophylactic...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4768900</comments>
            <pubDate>Tue, 26 Apr 2011 15:46:06 +0100</pubDate>
            <guid isPermaLink="false">4768900</guid>        </item>
        <item>
            <title>Erratum to: Antimicrobial resistance in community-acquired urinary tract infections: results from the Korean Antimicrobial Resistance Monitoring System</title>
            <link>http://www.medworm.com/index.php?rid=4749386&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7x504005150015xp%2F</link>
            <description>Content Type Journal ArticlePages 1-1DOI 10.1007/s10156-011-0248-8Authors
		Seung-Ju Lee, Department of Urology, St. Vincent’s Hospital, The Catholic University of Korea College of Medicine, Suwon, KoreaDong Sup Lee, Department of Urology, St. Vincent’s Hospital, The Catholic University of Korea College of Medicine, Suwon, KoreaHyun Sop Choe, Department of Urology, St. Vincent’s Hospital, The Catholic University of Korea College of Medicine, Suwon, KoreaBong Suk Shim, Department of Urology, Ewha Womans University, Seoul, KoreaChul Sung Kim, Department of Urology, Chosun University, Gwangju, KoreaMin Eui Kim, Department of Urology, Soonchunhyang University, Bucheon, KoreaYong-Hyun Cho, Department of Urology, St. Mary’s Hospital, The Catholic University of Korea College of Medicine...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4749386</comments>
            <pubDate>Thu, 21 Apr 2011 06:10:31 +0100</pubDate>
            <guid isPermaLink="false">4749386</guid>        </item>
        <item>
            <title>Two-way analysis for detecting factors affecting ventilator-associated pneumonia</title>
            <link>http://www.medworm.com/index.php?rid=4745349&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl57x7302441m4381%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The “clinically required ventilation period” for assessing ventilator-associated pneumonia (VAP) has not been studied because
 this period could not be clinically predicted. We addressed this problem using both rate analysis and failure-time analysis.
 A total of 325 patients who had received mechanical ventilatory support in the intensive care unit of a university hospital
 were reviewed. The total ventilation period and the ventilation period before VAP were compared using logistic regression
 and the Cox proportional hazard model for univariate and multivariate analyses. The Frechet distribution model was also used.
 Fifty patients were excluded for having pneumonia before intubation or for being admitted to a department in which no VAP
 occurred; 12 patients had...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4745349</comments>
            <pubDate>Tue, 19 Apr 2011 07:13:27 +0100</pubDate>
            <guid isPermaLink="false">4745349</guid>        </item>
        <item>
            <title>Chronological change of antibiotic use and antibiotic resistance in Escherichia coli causing urinary tract infections</title>
            <link>http://www.medworm.com/index.php?rid=4726669&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx161n7pr5755h0n4%2F</link>
            <description>In conclusion, we found changes in our pattern of antibiotic use associated with changes in antibiotic susceptibilities
 and an increase in ESBL-producing E. coli isolated from our UTI cases. Monitoring of antibiotic use and emergence of resistant strains should be continued.
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s10156-011-0241-2Authors
		Katsumi Shigemura, Department of Urology, Akashi Municipal Hospital, Akashi, JapanKazushi Tanaka, Division of Urology, Department of Organ Therapeutics, Faculty of Medicine, Kobe University Graduate School of Medicine, Kusunoki-cho, Chuo-ku, Kobe, 650-0017 JapanMasayo Adachi, Clinical Laboratories, Akashi Municipal Hospital, Akashi, JapanMasuo Yamashita, Department of Urology, Akashi Municipal Hospital, Akashi, JapanSoichi Arakawa, Divisi...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4726669</comments>
            <pubDate>Wed, 13 Apr 2011 14:36:52 +0100</pubDate>
            <guid isPermaLink="false">4726669</guid>        </item>
        <item>
            <title>Detection of methicillin-resistant Staphylococcus aureus with high-level resistance to mupirocin</title>
            <link>http://www.medworm.com/index.php?rid=4710881&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa36j7825455923m1%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;
 Staphylococcus aureus with high-level mupirocin resistance has rarely been isolated in Japan. We detected methicillin-resistant S. aureus (MRSA) with high-level mupirocin resistance (HLMR-MRSA; MIC ≥1,024&amp;nbsp;μg/ml) in a surveillance program of invasive MRSA infection
 in the Minami Ibaraki Area of Japan. The other 177 strains surveyed in the program showed susceptibility or low-level resistance
 to mupirocin. The HLMR-MRSA strain, named 115, was isolated from the blood of a patient with peripheral venous catheter-associated
 infection. The patient had not received administration of mupirocin before the isolation of strain 115. Another HLMR-MRSA
 strain, named 257, was recovered from the patient’s sputum obtained 1&amp;nbsp;year after the infection. Close relatednes...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4710881</comments>
            <pubDate>Mon, 11 Apr 2011 15:45:59 +0100</pubDate>
            <guid isPermaLink="false">4710881</guid>        </item>
        <item>
            <title>Patients in whom active tuberculosis was diagnosed after admission to a Japanese university hospital from 2005 through 2007</title>
            <link>http://www.medworm.com/index.php?rid=4710882&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fkur5724121427765%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;To identify problems in early diagnosis of tuberculosis and to design countermeasures against the disease, we examined the
 status of active tuberculosis among patients admitted to a university hospital that did not have an isolation ward for tuberculosis.
 Between 2005 and 2007, we analyzed demographic characteristics, disease type, chest radiologic findings, and the process leading
 to diagnosis. Active tuberculosis was diagnosed after admission in 55 patients (34 males and 21 females): pulmonary tuberculosis,
 26; tuberculous pleuritis, 13; tuberculous meningitis, 6; miliary tuberculosis, 4; tuberculous pericarditis, 3; lymph-node
 tuberculosis, 2; and tracheal and bronchial tuberculosis, 1. Although radiographic examinations provided abundant information,
 chest rad...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4710882</comments>
            <pubDate>Fri, 08 Apr 2011 05:54:37 +0100</pubDate>
            <guid isPermaLink="false">4710882</guid>        </item>
        <item>
            <title>Evaluation of resistance mechanisms and serotype and genotype distributions of macrolide-resistant strains in clinical isolates of Streptococcus pneumonia in Aydın, Turkey</title>
            <link>http://www.medworm.com/index.php?rid=4687343&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk0293884115h582n%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Macrolide resistance mechanisms in 89 Streptococcus pneumoniae strains isolated from several clinical samples between February 2007 and May 2009 were investigated. Erythromycin resistance
 was noted in 35 (40%) S. pneumoniae strains. In these strains, the most frequent resistance phenotype was cMLSB (74%), and the most frequent resistance genotype was ermB (82%). Both ermB and mefA genes were positive in 20% of macrolide-resistant strains. While no resistance to vancomycin, linezolid and telithromycin
 was noted in 89 S. pneumoniae strains, 12 (13%) strains were penicillin resistant, 26 (30%) strains were clindamycin resistant, 35 (40%) were azithromycin
 resistant, 32 (36%) strains were tetracycline resistant, and 1 (1%) strain was levofloxacin resistant. The serotype ...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4687343</comments>
            <pubDate>Sat, 02 Apr 2011 05:53:09 +0100</pubDate>
            <guid isPermaLink="false">4687343</guid>        </item>
        <item>
            <title>Nosocomial transmission of varicella to a healthcare provider positive for anti-varicella zoster virus antibodies: nonprotective positivity with an immune adherence hemagglutination assay</title>
            <link>http://www.medworm.com/index.php?rid=4659757&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft0g8253206h656m1%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A 24-year-old male healthcare provider, having attended a varicella patient 2&amp;nbsp;weeks before, developed varicella himself. He
 had shown a positive result for anti-VZV antibodies measured with an immune adherence hemagglutination assay (1:4) 1&amp;nbsp;year
 before. The present case shows that a positive result with this assay does not necessarily indicate protection against VZV
 infection.
 
 
	Content Type Journal ArticlePages 1-3DOI 10.1007/s10156-011-0236-zAuthors
		Shigemi Hitomi, Department of Infectious Diseases, Tsukuba University Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki 305-8576, JapanToyoichiro Kudo, Department of Pediatrics, Tsukuba University Hospital, Tsukuba, JapanHiroshi Koganemaru, Department of Infectious Diseases, Tsukuba University Hospital, 2-1-1 Ama...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4659757</comments>
            <pubDate>Mon, 28 Mar 2011 05:33:09 +0100</pubDate>
            <guid isPermaLink="false">4659757</guid>        </item>
        <item>
            <title>Evaluation of the safety and efficacy of micafungin in Japanese patients with deep mycosis: a post-marketing survey report</title>
            <link>http://www.medworm.com/index.php?rid=4645665&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm0553567tu8u1ml1%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The safety and efficacy of micafungin were evaluated in a Japanese post-marketing survey involving 1,142 patients with deep
 mycosis caused by Candida or Aspergillus. The overall clinical response was 83.0%, and the respective responses for patients with candidiasis or aspergillosis were
 86.3 and 70.8%. With regard to drug reactions, 562 adverse reactions were observed in 28.5% of patients. Among the 83 serious
 adverse drug reactions reported by 53 patients, a causal relationship with micafungin was assessed as definite or probable
 for 6 reactions in 5 patients. Age and baseline hepatic and renal function status did not affect the incidence of adverse
 reactions, although incidence increased significantly in proportion to the severity of mycosis and daily dose (p&amp;nbs...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4645665</comments>
            <pubDate>Fri, 25 Mar 2011 05:48:50 +0100</pubDate>
            <guid isPermaLink="false">4645665</guid>        </item>
        <item>
            <title>Anorectal syphilis mimicking Crohn’s disease</title>
            <link>http://www.medworm.com/index.php?rid=4645666&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F53246278531261xw%2F</link>
            <description>In this report,
 we describe a rare case of primary anorectal syphilis with clinical, endoscopic and histologic features that was misdiagnosed
 as Crohn’s disease.
 
 
	Content Type Journal ArticlePages 1-3DOI 10.1007/s10156-011-0234-1Authors
		Mesut Yilmaz, Infectious Diseases and Clinical Microbiology, Istanbul Medipol University, Ataturk Bulvari No: 27, Unkapani, Fatih, 34083 Istanbul, TurkeyReşat Memisoglu, Gastroenterology Unit, Gayrettepe Florence Nightingale Hospital, Istanbul, TurkeySelda Aydin, Cerrahpasa Medical Faculty, Department of Infectious Diseases and Clinical Microbiology, Istanbul University, Istanbul, TurkeyOmur Tabak, Department of Internal Medicine, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, TurkeyBilgül Mete, Cerrahpasa Medical Faculty, Departm...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4645666</comments>
            <pubDate>Fri, 25 Mar 2011 05:48:48 +0100</pubDate>
            <guid isPermaLink="false">4645666</guid>        </item>
        <item>
            <title>Urethritis due to Corynebacterium glucuronolyticum</title>
            <link>http://www.medworm.com/index.php?rid=4645667&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl00284886850238h%2F</link>
            <description>We describe a case of urethritis in a young man caused by Corynebacterium glucuronolyticum. This bacterium is a synonym of Corynebacterium seminale, a known agent of non-gonococcal urethritis, that cannot be regarded as commensal flora in the urogenital region when is
 isolated in a symptomatic clinical context. Accuracy in diagnosis and correct treatment is important for avoiding probable
 complications, for example prostatitis. Bacterial isolation is convenient, and an antimicrobial susceptibility test should
 be conducted to discover antimicrobial resistance. In our case the patient was successfully treated with fluoroquinolones
 and was symptom-free in 2&amp;nbsp;weeks.
 
 
	Content Type Journal ArticlePages 1-2DOI 10.1007/s10156-011-0237-yAuthors
		Fátima Galan-Sanchez, Clinical Microbio...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4645667</comments>
            <pubDate>Fri, 25 Mar 2011 05:48:46 +0100</pubDate>
            <guid isPermaLink="false">4645667</guid>        </item>
        <item>
            <title>Association between the number of blood cultures and appropriateness of care for suspected bacteremic urinary tract infection in the elderly</title>
            <link>http://www.medworm.com/index.php?rid=4645668&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu7u7048216140553%2F</link>
            <description>The objective of this study was to evaluate the association between the number of blood cultures collected and the appropriateness
 of care for suspected bacteremic community-acquired urinary tract infection (UTI) in the elderly. We retrospectively evaluated
 the medical records of 129 patients with UTI &amp;gt;65&amp;nbsp;years old admitted to a large community-based training hospital in Japan
 from 1 January 2006 to 31 December 2009. We assessed the association between the number of blood cultures collected and the
 appropriateness of care received, as well as other factors. Two-thirds of the patients were women, and patients &amp;gt;85&amp;nbsp;years
 old accounted for 45.0% of the cases. Most of the organisms isolated from the urine and blood were Escherichia coli (65.4–67.0%). More than two blood c...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4645668</comments>
            <pubDate>Fri, 25 Mar 2011 05:48:45 +0100</pubDate>
            <guid isPermaLink="false">4645668</guid>        </item>
        <item>
            <title>Two unexpected phenomena in macrolide-resistant Mycoplasma pneumoniae infection in Japan and the unique biological characteristics of Mycoplasma pneumoniae</title>
            <link>http://www.medworm.com/index.php?rid=4645670&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F315848685486g242%2F</link>
            <description>Content Type Journal ArticlePages 1-2DOI 10.1007/s10156-011-0235-0Authors
		Mitsuo Narita, Department of Pediatrics, Sapporo Tokushukai Hospital, Sakae-dori 18-4-10, Shiroishi-ku, Sapporo, 003-0021 Japan
	

	
		Journal Journal of Infection and ChemotherapyOnline ISSN 1437-7780Print ISSN 1341-321X (Source: Journal of Infection and Chemotherapy)</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4645670</comments>
            <pubDate>Fri, 25 Mar 2011 05:48:44 +0100</pubDate>
            <guid isPermaLink="false">4645670</guid>        </item>
        <item>
            <title>Emergence of NDM-1-positive capsulated Escherichia coli with high resistance to serum killing in Japan</title>
            <link>http://www.medworm.com/index.php?rid=4645669&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb45226rn673t1k8k%2F</link>
            <description>In this study, we characterized the bla
 NDM-1-positive ST38 Escherichia coli strain NDM-1 Dok01 (which was isolated from the blood of a 54-year-old Japanese inpatient, who had previously visited India),
 focusing on bacterial surface structures related to virulence. The E. coli culture contained colony variants, which developed a transparent smooth colony and a rough colony on blood agar plates. The
 smooth colony-forming cells (substrain M1) possessed a surface capsule and were resistant to serum killing, whereas rough
 colony-forming mutants (substrain B2) lacked a capsule (and a 5.3-kb plasmid) and were highly susceptible to serum killing.
 Reflecting the surface structural difference, substrain M1 was more flagellated and motile, whereas substrain B2 was less
 flagellated and apparent...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4645669</comments>
            <pubDate>Fri, 25 Mar 2011 05:48:44 +0100</pubDate>
            <guid isPermaLink="false">4645669</guid>        </item>
        <item>
            <title>Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2008: general view of the pathogens’ antibacterial susceptibility</title>
            <link>http://www.medworm.com/index.php?rid=4611759&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fcgv263k4h0517357%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;For the purpose of nationwide surveillance of the antimicrobial susceptibility of bacterial respiratory pathogens collected
 from patients in Japan, the Japanese Society of Chemotherapy conducted a third year of nationwide surveillance during the
 period from January to April 2008. A total of 1,097 strains were collected from clinical specimens obtained from well-diagnosed
 adult patients with respiratory tract infections. Susceptibility testing was evaluable with 987 strains (189 Staphylococcus aureus, 211 Streptococcus pneumoniae, 6 Streptococcus pyogenes, 187 Haemophilus influenzae, 106 Moraxella catarrhalis, 126 Klebsiella pneumoniae, and 162 Pseudomonas aeruginosa). A total of 44 antibacterial agents, including 26 β-lactams (four penicillins, three penicillins in ...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4611759</comments>
            <pubDate>Wed, 16 Mar 2011 11:52:02 +0100</pubDate>
            <guid isPermaLink="false">4611759</guid>        </item>
        <item>
            <title>Evaluation by Monte Carlo simulation of levofloxacin dosing for complicated urinary tract infections caused by Escherichia coli or Pseudomonas aeruginosa</title>
            <link>http://www.medworm.com/index.php?rid=4611758&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F53k5091373181007%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We evaluated, by Monte Carlo simulation, 500-mg once-daily, 100-mg thrice-daily, 200-mg twice-daily, and 200-mg thrice-daily
 dose regimens of levofloxacin (LVFX), for the ratio of area under the concentration–time curve for 24&amp;nbsp;h (AUC0–24) to minimum inhibitory concentration (MIC) (AUC0–24/MIC) and the ratio of maximum plasma concentration (C
 max) to MIC (C
 max/MIC), which predict microbiological outcomes, and the C
 max/MIC, which inhibits fluoroquinolone resistance selection, in complicated urinary tract infections (UTIs) with Escherichia coli or Pseudomonas aeruginosa. Monte Carlo simulation was performed for 10000 cases using the pharmacokinetic data of patients with complicated UTIs and
 the LVFX MIC distributions for E. coli or P. aeruginosa clinical ...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4611758</comments>
            <pubDate>Wed, 16 Mar 2011 11:52:02 +0100</pubDate>
            <guid isPermaLink="false">4611758</guid>        </item>
        <item>
            <title>Nocardia beijingensis pulmonary infection successfully treated with intravenous beta-lactam antibiotics and oral minocycline</title>
            <link>http://www.medworm.com/index.php?rid=4611760&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu7017156457530kp%2F</link>
            <description>We report a case of pulmonary infection caused by a rare Nocardia species, Nocardia beijingensis, in a 48-year-old man who received multiple immunosuppressive therapy after renal transplantation. This pathogen was isolated
 from a bronchoscopic protected specimen brush and was identified as N. beijingensis by 16S rRNA gene sequence analysis. The patient was initially treated with imipenem/cilastatin followed by ceftriaxone and
 oral minocycline. Traditionally, trimethoprim-sulfamethoxazole (SXT) has been one of the first-line antibiotics chosen as
 an initial therapy for pulmonary nocardiosis, but this case was successfully treated without SXT. Considering recent reports
 about failures of both prophylaxis and treatment for nocardial infections with SXT and its various side effects, treatm...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4611760</comments>
            <pubDate>Wed, 16 Mar 2011 11:52:00 +0100</pubDate>
            <guid isPermaLink="false">4611760</guid>        </item>
        <item>
            <title>Penicilliosis presenting as fungating skin lesion</title>
            <link>http://www.medworm.com/index.php?rid=4611762&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F330386858765p2x6%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A 35-year-old HIV seropositive male patient presented with fever, weight loss, papules, nodules and fungating masses all over
 the body. Histopathological and mycological study of the skin biopsy tissue confirmed the diagnosis of penicilliosis. Although
 penicilliosis is restricted to Southeast Asia, more cases are being recognized in nonendemic countries.
 
 
	Content Type Journal ArticlePages 1-3DOI 10.1007/s10156-011-0227-0Authors
		Uday Yanamandra, Department of Internal Medicine, Armed Forces Medical College, Pune, 411040 Maharashtra IndiaJairam Anantaram, Department of Internal Medicine, Armed Forces Medical College, Pune, 411040 Maharashtra IndiaShankar Subramanian, Department of Internal Medicine, Armed Forces Medical College, Pune, 411040 Maharashtra IndiaMande...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4611762</comments>
            <pubDate>Wed, 16 Mar 2011 11:51:59 +0100</pubDate>
            <guid isPermaLink="false">4611762</guid>        </item>
        <item>
            <title>Acute meningitis as an initial manifestation of Erysipelothrix rhusiopathiae endocarditis</title>
            <link>http://www.medworm.com/index.php?rid=4611761&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F317838g6730g0045%2F</link>
            <description>We report a case of community-acquired meningitis as
 an initial manifestation of E. rhusiopathiae endocarditis in a 56-year-old woman, who had no history of exposure to animals.
 
 
	Content Type Journal ArticlePages 1-3DOI 10.1007/s10156-011-0230-5Authors
		Eun-Jeong Joo, Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul, 135-710 Republic of KoreaCheol-In Kang, Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul, 135-710 Republic of KoreaWook Sung Kim, Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, R...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4611761</comments>
            <pubDate>Wed, 16 Mar 2011 11:51:59 +0100</pubDate>
            <guid isPermaLink="false">4611761</guid>        </item>
        <item>
            <title>Real-time estimation and prediction for pandemic A/H1N1(2009) in Japan</title>
            <link>http://www.medworm.com/index.php?rid=4578678&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ftk2x6706q4k03j57%2F</link>
            <description>In conclusion, for the first time in the world, we successfully
 demonstrated real-time estimation and prediction for the entire course of a pandemic, and which could be used routinely for
 planning counter-measures.
 
 
	Content Type Journal ArticlePages 1-5DOI 10.1007/s10156-010-0200-3Authors
		Yasushi Ohkusa, Infectious Diseases Surveillance Center, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku, Tokyo, JapanTamie Sugawara, Infectious Diseases Surveillance Center, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku, Tokyo, JapanKiyosu Taniguchi, Infectious Diseases Surveillance Center, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku, Tokyo, JapanNobuhiko Okabe, Infectious Diseases Surveillance Center, National Institute of Infectious...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4578678</comments>
            <pubDate>Tue, 08 Mar 2011 17:03:53 +0100</pubDate>
            <guid isPermaLink="false">4578678</guid>        </item>
        <item>
            <title>Clinical and microbiological evaluation of hemodialysis-associated pneumonia (HDAP): should HDAP be included in healthcare-associated pneumonia?</title>
            <link>http://www.medworm.com/index.php?rid=4562240&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe7114663836h1658%2F</link>
            <description>This study aimed to reveal microbiological characteristics
 and clinical outcomes of HDAP and to assess whether HDAP should be included in the HCAP category. We retrospectively analyzed
 69 HDAP patients [42 with moderate and 27 with severe disease based on A-DROP (age, dehydration, respiratory failure, orientation
 disturbance, and low blood pressure)] in whom sputum cultures were performed at our hospital between 2007 and 2009. The most
 common pathogens were Staphylococcus aureus (37.7%), which were composed of methicillin-resistant S. aureus (MRSA) (27.5%) and methicillin-sensitive S. aureus (MSSA) (10.1%), followed by Streptococcus pneumoniae (10.1%), Klebsiella pneumoniae (8.7%), Haemophilus influenzae (7.2%), and Moraxella catarrhalis (5.8%). This distribution mostly resembled the m...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4562240</comments>
            <pubDate>Thu, 03 Mar 2011 07:37:40 +0100</pubDate>
            <guid isPermaLink="false">4562240</guid>        </item>
        <item>
            <title>Investigation of emtricitabine-associated skin pigmentation and safety in HIV-1-infected Japanese patients</title>
            <link>http://www.medworm.com/index.php?rid=4562239&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn70k162xj36p8622%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Emtricitabine (FTC) has been reported to cause skin pigmentation (SP), and the incidence of SP associated with FTC varied
 with ethnicity, with a higher rate in African-American patients (8%). We assessed the incidence of SP in Japanese HIV-1-infected
 patients receiving combination antiretroviral therapy (cART) with FTC for a period of 48&amp;nbsp;weeks and confirmed new findings
 of FTC-associated SP, including pathological characteristics. This was a multicenter, prospective, longitudinal non-randomized
 study. We evaluated the appearance of SP at 48&amp;nbsp;weeks as the primary endpoint in 155 Japanese patients, and secondary endpoints
 included the characteristics of the SP (location, color tone, size, and progression). Six cases (3.9%) of SP occurred at a
 median of 124&amp;...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4562239</comments>
            <pubDate>Thu, 03 Mar 2011 07:37:40 +0100</pubDate>
            <guid isPermaLink="false">4562239</guid>        </item>
        <item>
            <title>Comparison of the efficacies of amantadine treatment of swine-origin influenza virus A H1N1 and seasonal influenza H1N1 and H3N2 in Japan (2008–2009)</title>
            <link>http://www.medworm.com/index.php?rid=4541777&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fqh10x300543r6611%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Amantadine is not thought to be effective for the treatment of swine-origin influenza virus (S-OIV) based on an analysis of
 genetic sequences of the M2 protein. However, the actual clinical efficacy of amantadine has not been well documented. Here,
 we were able to compare the efficacies of amantadine and neuraminidase inhibitors. Subjects consisted of 428 patients, including
 144 with seasonal influenza (flu) identified between 2008 and 2009, and 284 with S-OIV identified between July 1 and November
 30, 2009. Diagnosis of flu was established using a rapid diagnostic kit obtained commercially in Japan. Body temperature sheets
 were obtained from 95% of the S-OIV patients. Times required to recover normal body temperature were compared among subjects
 using different a...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4541777</comments>
            <pubDate>Mon, 28 Feb 2011 06:43:53 +0100</pubDate>
            <guid isPermaLink="false">4541777</guid>        </item>
        <item>
            <title>Prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae among healthy adult people in Japan</title>
            <link>http://www.medworm.com/index.php?rid=4541778&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl072141414452k05%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In Japan, the prevalence of extended-spectrum β-lactamase (ESBL) producers in hospital settings has shown an increasing trend.
 In the present study, we investigated the prevalence of the fecal carriage of ESBL-producing Enterobacteriaceae among healthy adults. Stool samples were collected for the phenotypic and genotypic identification of ESBL-producing Enterobacteriaceae. We found the prevalence of ESBL producers to be 6.4% by phenotypic identification, and 92.9% of them possessed the bla
 CTX-M gene. Among the CTX-M ESBL-producing Enterobacteriaceae, we identified 11 Escherichia coli and 2 Klebsiella pneumonia strains. The findings suggest that the fecal carriage of CTX-M-type ESBL producers by healthy people is rapidly increasing
 in Japan. This may be one of the c...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4541778</comments>
            <pubDate>Fri, 25 Feb 2011 17:06:52 +0100</pubDate>
            <guid isPermaLink="false">4541778</guid>        </item>
        <item>
            <title>A successful strategy for the use of synergistic intravenous streptomycin in a hemodialysis patient with refractory Enterococcus faecalis bacteremia</title>
            <link>http://www.medworm.com/index.php?rid=4541779&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fpj5716r473612761%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Streptomycin has been available for over 60&amp;nbsp;years, yet optimal dosing in hemodialysis (HD) patients is not well defined. We
 report the successful treatment of enterococcal bacteremia in an HD patient with intravenous (IV) penicillin G and IV streptomycin
 at a dose of 7.5&amp;nbsp;mg/kg after HD sessions.
 
 
	Content Type Journal ArticlePages 1-2DOI 10.1007/s10156-011-0226-1Authors
		Heather Young, Division of Infectious Diseases, Department of Medicine, Denver Health Medical Center, 777 Bannock St, MC 4000, Denver, CO 80204, USAClaire J. Swartwood, Department of Pharmacy, Denver Health Medical Center, Denver, CO USATimothy C. Jenkins, Division of Infectious Diseases, Department of Medicine, Denver Health Medical Center, 777 Bannock St, MC 4000, Denver, CO 80204, USA...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4541779</comments>
            <pubDate>Thu, 24 Feb 2011 17:28:08 +0100</pubDate>
            <guid isPermaLink="false">4541779</guid>        </item>
        <item>
            <title>Dissemination of multiple MRSA clones among community-associated methicillin-resistant Staphylococcus aureus infections from Japanese children with impetigo</title>
            <link>http://www.medworm.com/index.php?rid=4503272&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7m86j5t21777j45l%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The proportion of MRSA strains that cause skin and soft infections has recently increased. In 3&amp;nbsp;months we have characterized
 17 MRSA strains isolated from children with impetigo at a Japanese hospital. Seventeen MRSA strains belonged to 7 clones defined
 by clonal complex (CC) in MLST genotype and type of SCCmec, which were rarely identified among healthcare-associated MRSA: CC 91-SCCmecIIb (4 strains); CC91-SCCmecIIn (2 strains); CC91-SCCmecIVa (2 strains); CC91-SCCmecV (4 strains); CC88-SCCmecIVg (3 strains); CC1-SCCmecIVc (1 strain); and CC5-SCCmecIVn (1 strain). Although one strain belonged to CC5, which has been commonly identified in healthcare-associated MRSA, it
 did not carry type II SCCmec, but carried type IV SCCmec. Fourteen of the 17 strains carried e...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4503272</comments>
            <pubDate>Thu, 17 Feb 2011 07:07:01 +0100</pubDate>
            <guid isPermaLink="false">4503272</guid>        </item>
        <item>
            <title>In vitro effectiveness of antifungal lock solutions on catheters infected with Candida species</title>
            <link>http://www.medworm.com/index.php?rid=4503273&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fem5r587k17544j30%2F</link>
            <description>In this study, the effectiveness of the commercially available antifungal drugs, which are commonly
 used in candidemia, were assessed in an in vitro antibiotic lock model. Amphotericin B, caspofungin, fluconazole, itraconazole,
 and voriconazole were used as lock solutions against catheters infected with slime-forming Candida albicans and Candida parapsilosis. Infected catheters were exposed to each of the antifungal lock solution (300-, 500- and 1,000-fold MIC) for 1, 3, 5, and
 7&amp;nbsp;days. The presence of the remaining Candida in the catheter was evaluated quantitatively. Among the antifungal agents, amphotericin B and caspofungin lock solutions
 decreased the yeast colony count significantly from baseline starting on the first day of treatment (P&amp;nbsp;&amp;lt;&amp;nbsp;0.001). Significant dec...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4503273</comments>
            <pubDate>Thu, 17 Feb 2011 07:07:00 +0100</pubDate>
            <guid isPermaLink="false">4503273</guid>        </item>
        <item>
            <title>A case of isoniazid-resistant miliary tuberculosis in which tuberculous meningitis paradoxically developed despite systemic improvement</title>
            <link>http://www.medworm.com/index.php?rid=4496244&amp;cid=s_33353_20_f&amp;fid=33353&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F02656516172x15m1%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A 63-year-old man with chronic myelomonocytic leukemia was admitted to our hospital with miliary tuberculosis. He received
 anti-tuberculosis drugs: isoniazid (INH), rifampicin (RFP), ethambutol (EB), and pyrazinamide (PZA). His condition clearly
 and immediately improved after the therapy, but he experienced a high fever of about 38°C every day from 1&amp;nbsp;month after the
 initiation of the therapy. Drug-induced fever and tumor fever were suspected as causes, but the etiology could not be determined.
 The tuberculosis was identified as an INH-resistant strain, so INH was stopped and levofloxacin (LVFX) was introduced, with
 streptomycin (SM), in addition to RFP, EB, and PZA. At 2&amp;nbsp;months after the initiation of the therapy (about one week after
 the change in the ...</description>
            <author>Journal of Infection and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4496244</comments>
            <pubDate>Wed, 16 Feb 2011 07:02:01 +0100</pubDate>
            <guid isPermaLink="false">4496244</guid>        </item>
    </channel>
</rss>

